<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-128632" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Nuclear Medicine Pediatric Assessment, Protocols, and Interpretation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Djekidel</surname>
            <given-names>Mehdi</given-names>
          </name>
          <aff>Sidra Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Govindarajan</surname>
            <given-names>Krishna Kumar</given-names>
          </name>
          <aff>JIPMER</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mehdi Djekidel declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Krishna Kumar Govindarajan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>5</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-128632.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Nuclear medicine and other radiological techniques impart some ionizing radiation exposure to patients. Within the pediatric population, the disease distribution of pathology is also different compared to adults. With this in mind, applications differ slightly compared to the adult population. This article outlines the appropriate use of nuclear medicine techniques in the pediatric population.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Explain the concept of standard of care and problem-solving exams in pediatric nuclear medicine.</p></list-item><list-item><p>Summarize high yield exams in pediatric nuclear medicine.</p></list-item><list-item><p>Outline the applications of Nuclear medicine in pediatric oncology.</p></list-item><list-item><p>Describe the optimal strategy to address radiation exposure in pediatric nuclear medicine.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=128632&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=128632">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-128632.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Pediatric imaging relies heavily on morphological imaging using mostly nonionizing radiation techniques such as ultrasound (US) and magnetic resonance imaging (MRI). Computed tomography (CT) and nuclear medicine (NM) techniques still hold value and are used in high-yield indications. Although nuclear medicine exams have been around for a century, it is only with recent software and hardware improvements that they have gained an impactful clinical role.</p>
        <p>Even though the Society for Nuclear Medicine was founded in 1954, the pediatric nuclear medicine&#x000a0;organization known nowadays as the Pediatric Council was only created in the 1970s; we can date to 1946 an NRC report in pediatrics looking at radioisotopes in thyroid pathology. The American medical association (AMA) recognized nuclear medicine as an independent specialty in 1971, leading to the creation of the American Board of Nuclear Medicine (ABNM). The various modalities of nuclear medicine in children have led to prompt diagnosis, selection of appropriate procedures, and treatment resulting in improved outcomes.</p>
      </sec>
      <sec id="article-128632.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>Children&#x000a0;do not act as a&#x000a0;scaled-down version of adults. They are unique in terms of anatomy, physiology, and pathology. The biology can be different even within the same disease type. For similar pathology, age can also be a critical prognostic determinant. Radiation exposure is a concern in pediatrics compared to adults. It is felt that children depending on their age, might be slightly more radiosensitive. Additionally, some nuclear medicine procedures evaluate physiological changes in vivo and real-time as they occur through pharmacologic interventions.</p>
        <p>In other cases, nonradioactive drugs are used to prepare the patient and optimize radiopharmaceutical uptake for a specific study. There should also be special attention to potential interfering drugs with the uptake mechanism of the radiopharmaceutical. Examples of non-radioactive medications used for the preparation or during the exam include furosemide, acetazolamide, phenobarbital, cholecystokinin analog, angiotensin-converting enzyme inhibitors, adenosine analogs, and dobutamine.</p>
      </sec>
      <sec id="article-128632.s4" sec-type="Indications">
        <title>Indications</title>
        <p>Nuclear medicine techniques are highly sensitive. They play a major role in several instances in pediatrics. The major aspect that needs to be considered is that they are used as a standard of care or problem-solving tool, occasionally both, and how they will guide clinical management. The key indications for nuclear medicine techniques are the evaluation of:</p>
        <list list-type="order">
          <list-item>
            <p>Lymphoma</p>
          </list-item>
          <list-item>
            <p>Sarcoma</p>
          </list-item>
          <list-item>
            <p>Neuroblastoma</p>
          </list-item>
          <list-item>
            <p>Pheochromocytoma and paraganglioma</p>
          </list-item>
          <list-item>
            <p>Miscellaneous tumors</p>
          </list-item>
          <list-item>
            <p>Thyroid cancer</p>
          </list-item>
          <list-item>
            <p>Congenital hypothyroidism</p>
          </list-item>
          <list-item>
            <p>Hyperparathyroidism</p>
          </list-item>
          <list-item>
            <p>Chronic urinary tract infections and kidney scarring</p>
          </list-item>
          <list-item>
            <p>Vesicoureteral reflux and scarring</p>
          </list-item>
          <list-item>
            <p>Obstructive uropathies</p>
          </list-item>
          <list-item>
            <p>Lymphodysplasias</p>
          </list-item>
          <list-item>
            <p>Biliary atresia</p>
          </list-item>
          <list-item>
            <p>Myocardial ischemia</p>
          </list-item>
          <list-item>
            <p>Meckel's diverticulum</p>
          </list-item>
          <list-item>
            <p>Medically refractory epilepsy</p>
          </list-item>
          <list-item>
            <p>Encephalitis</p>
          </list-item>
          <list-item>
            <p>Brain tumors</p>
          </list-item>
          <list-item>
            <p>Child abuse</p>
          </list-item>
          <list-item>
            <p>Lung perfusion pathology</p>
          </list-item>
          <list-item>
            <p>Gastrointestinal motility disorders</p>
          </list-item>
          <list-item>
            <p>Chronic microaspirations</p>
          </list-item>
          <list-item>
            <p>Gastroesophageal reflux</p>
          </list-item>
          <list-item>
            <p>Fever of unknown origin</p>
          </list-item>
          <list-item>
            <p>Evaluation of infectious foci/device infections</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-128632.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Nuclear medicine scans are very safe as the radiopharmaceutical contains a trace amount of the biological compound and therefore has no pharmacological effect. Contraindications would relate to the appropriateness of the test ordered according to the latest guidelines and appropriateness use criteria.</p>
        <p>Other contraindications would be related to the use of sedation which is frequently needed in pediatrics. Additionally, when performed, close attention should be paid to any contraindications specific to administering a medication required for the test, including a pharmacological stressor, vasodilator, diuretic, or an angiotensin-converting enzyme inhibitor, or other.</p>
      </sec>
      <sec id="article-128632.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>The latest equipment should be obtained. This is especially critical in pediatrics as newer scanners offer much higher temporal and spatial resolutions at lower injected doses, minimizing radiation exposure to the patient. Following strict quality control protocols in the radiopharmacy and the scanner, rooms are&#x000a0;critical&#x000a0;in delivering the highest quality and safe patient care.</p>
        <p>Proper planned maintenance and upkeep of the nuclear medicine equipment is&#x000a0;also essential in order to avoid equipment failures and artifacts that may affect the interpretation of studies. The latest total-body PET scanners offer the potential of imaging with a radiation exposure equivalent to a chest X-ray.<xref ref-type="bibr" rid="article-128632.r1">[1]</xref><xref ref-type="bibr" rid="article-128632.r2">[2]</xref><xref ref-type="bibr" rid="article-128632.r3">[3]</xref>&#x000a0;This is likely to be valuable and transformative in pediatric oncology patients that may require multiple successive scans to assess response to treatment and monitor disease progression.</p>
      </sec>
      <sec id="article-128632.s7" sec-type="Personnel">
        <title>Personnel</title>
        <p>Fully trained, board-certified, and licensed nuclear medicine technologists under the supervision of a qualified, licensed, and board-certified nuclear medicine physician oversees the full spectrum of pediatric nuclear medicine. Specific expertise in pediatric nuclear medicine is also important. Certified child life&#x000a0;specialists are an integral part of the care team. Qualified pediatric nurses are important for difficult intravenous access and for studies that require the administration of medications.</p>
        <p>The anesthesiologist and anesthesiologist technologist play an important role in adult nuclear medicine practice that requires very rarely any sedatives. Proper communication between all these team members and advanced group coordination and planning for challenging cases is necessary.</p>
      </sec>
      <sec id="article-128632.s8" sec-type="Preparation">
        <title>Preparation</title>
        <p>Preparation for an exam in pediatric nuclear medicine involves several aspects:</p>
        <list list-type="order">
          <list-item>
            <p>As a rule, proper hydration is essential to optimize the study itself and decrease radiation exposure since hydration enhances rapid clearance of the radiopharmaceutical.</p>
          </list-item>
          <list-item>
            <p>Specific preparation will depend on the study performed and the radiopharmaceutical administered. For example, fasting for 4&#x000a0;to 6 hours is required for certain studies such as FDG PET (positron emission tomography) scans. However, this fast may be shortened to 2&#x000a0;or 3 hours in babies and for HIDA scans and gastric emptying studies.</p>
          </list-item>
          <list-item>
            <p>Special attention should be made to withhold any interfering medications.</p>
          </list-item>
          <list-item>
            <p>Child life involvement is frequently needed before the test to alleviate the child and family's anxiety and assist with the exam.</p>
          </list-item>
          <list-item>
            <p>A visit to nuclear medicine before the scan day and a tour of the scan room by the child may help prepare the child for the test.</p>
          </list-item>
          <list-item>
            <p>Making sure toys, snacks, ambiance, mood, relaxing music, and atmosphere are available is essential.</p>
          </list-item>
          <list-item>
            <p>Distraction devices are helpful in babies and younger children.</p>
          </list-item>
          <list-item>
            <p>Making sure that safe immobilization devices are available. This includes head holders or straps fitted to the patient's size; otherwise, they will not be effective.&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Informing the anesthesia team and other team members of the specific requirements of the nuclear medicine test allows for a smooth and safe workflow on the day of the test.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-128632.s9" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>Over the past decade, nuclear medicine has witnessed significant advances in software, hardware, and&#x000a0;novel radiopharmaceutical approvals. This includes SPECT, PET, and hybrid imaging. Many of these advancements have improved the quality of nuclear medicine imaging in children. The field has benefitted from a higher sensitivity and lower radiation exposure in pediatrics.</p>
        <p>In children, the acquisition and reconstruction protocols require to be closely monitored. Lower doses may require longer acquisition times. A good balance between dose and imaging time is needed. Motion has to be closely monitored. Strapping, swaddling, and use of varying levels of sedation may be required. Involving the parents and child life experts is essential. Dynamic imaging may be useless if affected by artifacts and cannot be repeated without adding another radiopharmaceutical dose to the patient.</p>
        <p>Using the latest software with at least half-time acquisitions and iterative reconstruction techniques is necessary when available.&#x000a0;Special expertise is needed to optimize and not hinder quality. Knowledge of all these techniques and how they apply to each patient and what factors may affect them is essential.</p>
      </sec>
      <sec id="article-128632.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Radiotracers have a very high safety profile because the active component used to target the specific biological process is present in trace amounts. Complications can be related to the intravenous cannulation process. The radiopharmaceutical injection rarely may cause a rash or swell at the injection site in case of extravasation. Very rarely, headaches and nausea have been reported. Additionally, complications/adverse events related to medication injected as a part of the procedure may be encountered, such as acetazolamide, dobutamine, adenosine, captopril, furosemide,&#x000a0;and others.</p>
      </sec>
      <sec id="article-128632.s11" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Nuclear medicine techniques play an important role in the care of pediatric patients. They&#x000a0;can&#x000a0;diagnose, change management, monitor progression and assess response to therapies.<xref ref-type="bibr" rid="article-128632.r4">[4]</xref><xref ref-type="bibr" rid="article-128632.r5">[5]</xref><xref ref-type="bibr" rid="article-128632.r6">[6]</xref>&#x000a0;One should note that children are not small adults, and they frequently require adjustments.</p>
        <list list-type="order">
          <list-item>
            <p><bold>Time requirements</bold>: Nuclear medicine exams require at least 2 to 3 times the time it takes to perform a similar test in adults. Therefore, proper planning and scheduling are required, especially in a medical practice with a mixed adult and pediatrics patient population, to avoid mistakes in scheduling and allow for the proper time to perform the test.</p>
          </list-item>
          <list-item>
            <p><bold>Early</bold>
<bold>team</bold> involvement (child life, nursing, and anesthesia) in difficult cases.</p>
          </list-item>
          <list-item>
            <p>Proper understanding that there is a&#x000a0;spectrum of findings in<bold>&#x000a0;</bold>normal--negative exams. This ranges from a typical/textbook normal to a normal variant versus atypical normal.</p>
          </list-item>
          <list-item>
            <p>Proper understanding that there is a&#x000a0;spectrum of findings in<bold>&#x000a0;</bold>abnormal--positive exams.&#x000a0;This ranges from a typical/textbook abnormal to an abnormal variant versus atypical abnormal.</p>
          </list-item>
          <list-item>
            <p>This spectrum knowledge is critical to avoid confusion every time an atypical presentation occurs.</p>
          </list-item>
          <list-item>
            <p>Proper understanding of the indication of the nuclear medicine exam. Some exams are ordered as a standard of care&#x000a0;in all patients with similar pathology. At the same time, others are ordered as problem-solving tools. At other times both apply.</p>
          </list-item>
          <list-item>
            <p><bold>Appropriate use criteria:</bold>&#x000a0;Because nuclear medicine exams involve exposure to ionizing radiation, it is essential to follow the best medical practice, guidelines, and appropriate use criteria as defined by leading medical societies and the literature.<xref ref-type="bibr" rid="article-128632.r7">[7]</xref><xref ref-type="bibr" rid="article-128632.r8">[8]</xref><xref ref-type="bibr" rid="article-128632.r9">[9]</xref><xref ref-type="bibr" rid="article-128632.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Optimized scanning time</bold>: Because children cannot lay still for the duration of scans, anesthesia may be used at times. Choosing the most appropriate imaging protocol that will provide diagnostic value in the least amount of time is needed. Purchasing the latest technology scanners&#x000a0;will allow diagnostic quality imaging&#x000a0;with&#x000a0;a rapid scanning time with the equivalent of a chest X-ray or lower radiation exposure dose.<xref ref-type="bibr" rid="article-128632.r1">[1]</xref><xref ref-type="bibr" rid="article-128632.r2">[2]</xref><xref ref-type="bibr" rid="article-128632.r3">[3]</xref><xref ref-type="bibr" rid="article-128632.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Optimized radiopharmaceutical activity</bold>:&#x000a0;Purchasing the latest technology scanners&#x000a0;will allow&#x000a0;diagnostic quality imaging at very low radiopharmaceutical doses, the equivalent of a chest x-ray, or lower radiation exposure dose.<xref ref-type="bibr" rid="article-128632.r1">[1]</xref><xref ref-type="bibr" rid="article-128632.r2">[2]</xref><xref ref-type="bibr" rid="article-128632.r3">[3]</xref><xref ref-type="bibr" rid="article-128632.r11">[11]</xref>&#x000a0;The image gently campaign was developed in late 2007 and since then has been advocating for lower radiation doses in nuclear medicine and diagnostic radiology. This campaign was accompanied by a harmonization in the injected radiopharmaceutical activities in pediatrics aiming for the ALARA principle.<xref ref-type="bibr" rid="article-128632.r12">[12]</xref><xref ref-type="bibr" rid="article-128632.r13">[13]</xref>&#x000a0;As low as reasonably achievable to get a diagnostic scan. The clinical shift occurred from pretty images to diagnostic images with no artifacts.<xref ref-type="bibr" rid="article-128632.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Benefits/risk estimate</bold>: Physicians should carefully weigh the benefit-risk ratio before ordering an exam, as with any procedure or test. The benefit of using diagnostic and therapeutic nuclear medicine techniques in pediatrics is huge when best medical practice and guidelines are followed.&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Indications</bold>:</p>
          </list-item>
        </list>
        <list list-type="order">
          <list-item>
            <p><bold>Lymphoma:&#x000a0;</bold>3rd most common malignancy in children. There are mostly two types: Hodgkin's lymphoma and non-Hodgkin's lymphoma. Better outcomes are noted in children compared to adults. However, long-term complications from treatment are center stage. Therefore, de-escalation treatment regimens are being explored that would improve outcomes and decrease immediate and late adverse effects. The role of FDG-PET is established in pediatric lymphomas and has become the standard of care in pediatric Hodgkin lymphoma initial staging, restaging, and response to therapy assessments.<xref ref-type="bibr" rid="article-128632.r15">[15]</xref><xref ref-type="bibr" rid="article-128632.r16">[16]</xref>&#x000a0;Early PET response in HL is an important prognostic indicator. Newer protocols use dynamic response assessments with FDG PET to modulate therapy or deescalate treatments. This latter is a crucial element to decrease long-term adverse effects from anti-cancer treatment.<xref ref-type="bibr" rid="article-128632.r17">[17]</xref><xref ref-type="bibr" rid="article-128632.r18">[18]</xref><xref ref-type="bibr" rid="article-128632.r19">[19]</xref><xref ref-type="bibr" rid="article-128632.r20">[20]</xref><xref ref-type="bibr" rid="article-128632.r21">[21]</xref><xref ref-type="bibr" rid="article-128632.r22">[22]</xref><xref ref-type="bibr" rid="article-128632.r23">[23]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Sarcomas:&#x000a0;</bold>Bone sarcomas account for approximately 6 percent of all childhood cancers, and osteosarcomas account for approximately 3 percent of childhood cancers overall. Bone scans can be used to evaluate multifocal disease. However, this is being replaced nowadays with FDG PET-CT scans for staging and restaging assessments. Although whole-body MRI (magnetic resonance imaging) is the mainstay of imaging, it may have some limitations at follow-up with prostheses artifacts and assessing response to treatment. A CT scan with thin slices is required to monitor for any lung metastasis. FDG PET-CT is very good at initial staging, restaging, therapy response assessments, and reports showing sensitivity and specificity in the '90s. One should pay close attention to the PET-CT protocol used and adjust the attenuation correction CT protocol to be able to detect small lung nodule metastasis. This is crucial considering the lung is the site of 80% of metastasis.<xref ref-type="bibr" rid="article-128632.r24">[24]</xref><xref ref-type="bibr" rid="article-128632.r25">[25]</xref><xref ref-type="bibr" rid="article-128632.r26">[26]</xref>&#x000a0;Quantitative parameters such as metabolic tumor volume and total lesion glycolysis may be best used to assess response to treatment.<xref ref-type="bibr" rid="article-128632.r27">[27]</xref>&#x000a0;FDG PET&#x000a0;at 6 weeks&#x000a0;can predict neoadjuvant chemotherapy effect on time to progression and pathologic response. FDG PET was also described to be of prognostic value.<xref ref-type="bibr" rid="article-128632.r28">[28]</xref><xref ref-type="bibr" rid="article-128632.r24">[24]</xref><xref ref-type="bibr" rid="article-128632.r29">[29]</xref><xref ref-type="bibr" rid="article-128632.r30">[30]</xref><xref ref-type="bibr" rid="article-128632.r31">[31]</xref><xref ref-type="bibr" rid="article-128632.r24">[24]</xref>&#x000a0;The Children's oncology group recommends FDG PET and or SPECT Bone scanning at initial diagnosis and before any surgery or local control intervention. FDG PET or SPECT bone scanning is also recommended at follow-up surveillance on chemotherapy or post-chemotherapy patients if symptoms arise or if metastatic disease is present on a prior scan.</p>
          </list-item>
          <list-item>
            <p><bold>Neuroblastoma: </bold>Represents&#x000a0;10% of solid tumors in&#x000a0;children. It&#x000a0;is the most common extracranial solid tumor.<xref ref-type="bibr" rid="article-128632.r32">[32]</xref>&#x000a0;123-I Metaiodobenzylguanadine (MIBG) is used in conjunction with MRI or CT to stage these patients. MIBG is structurally similar to norepinephrine and concentrates in secretory granules of catecholamine-producing neural crest cells. It has high sensitivity and specificity of up&#x000a0;to 90%.<xref ref-type="bibr" rid="article-128632.r33">[33]</xref>&#x000a0;Using the latest hybrid imaging SPECT-CT techniques is recommended.<xref ref-type="bibr" rid="article-128632.r34">[34]</xref>&#x000a0;Bone scans are rarely used nowadays but may be helpful if&#x000a0;MIBG or PET radiopharmaceuticals&#x000a0;are not readily available. Novel PET radiopharmaceuticals&#x000a0;such as Iodine 124 MIBG, 18F FDOPA, and 68Ga DOTATATE show higher sensitivities and specificities.<xref ref-type="bibr" rid="article-128632.r35">[35]</xref><xref ref-type="bibr" rid="article-128632.r36">[36]</xref><xref ref-type="bibr" rid="article-128632.r37">[37]</xref><xref ref-type="bibr" rid="article-128632.r38">[38]</xref><xref ref-type="bibr" rid="article-128632.r39">[39]</xref>&#x000a0;The higher spatial resolution of PET imaging also allows for improved dosimetry when radionuclide therapies are contemplated.<xref ref-type="bibr" rid="article-128632.r40">[40]</xref><xref ref-type="bibr" rid="article-128632.r41">[41]</xref>&#x000a0;FDG PET is also used in MIBG negative cases and may offer some prognostic value.<xref ref-type="bibr" rid="article-128632.r42">[42]</xref><xref ref-type="bibr" rid="article-128632.r43">[43]</xref><xref ref-type="bibr" rid="article-128632.r44">[44]</xref>&#x000a0;Considering the heterogeneity of the disease, combining two radiopharmaceuticals may potentially play an important role.<xref ref-type="bibr" rid="article-128632.r45">[45]</xref>&#x000a0;A novel fluorinated MFBG PET imaging probe is shown to be almost twice more sensitive than Iodine123 MIBG on a lesional analysis basis.<xref ref-type="bibr" rid="article-128632.r46">[46]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Pheochromocytoma/p</bold><bold>araganglioma: </bold>These are rare pediatric tumors. Pheochromocytomas usually arise from the adrenals and paragangliomas from extra-adrenal locations. Pheocromoyctomas frequently will secrete catecholamines, and paragangliomas are quite variable. About two-thirds are sporadic, but several germline mutations have been described, such as&#x000a0;<italic toggle="yes">RET</italic>,&#x000a0;<italic toggle="yes">SDHD</italic>,&#x000a0;<italic toggle="yes">SDHB</italic>,&#x000a0;<italic toggle="yes">SDHC</italic>,&#x000a0;<italic toggle="yes">SDHAF2</italic>, or&#x000a0;<italic toggle="yes">SDHA</italic>, <italic toggle="yes">VHL</italic>,&#x000a0;<italic toggle="yes">TMEM127,</italic>&#x000a0;or&#x000a0;<italic toggle="yes">MAX</italic>&#x000a0;genes.<xref ref-type="bibr" rid="article-128632.r47">[47]</xref><xref ref-type="bibr" rid="article-128632.r48">[48]</xref><xref ref-type="bibr" rid="article-128632.r49">[49]</xref>&#x000a0;MIBG scans have traditionally been used to evaluate pheochromocytoma and paragangliomas. The overall limited accuracy has been partially overcome by the use of novel hybrid SPECT-CT techniques. However, newer techniques using PET radiopharmaceuticals are more sensitive and should preferably be used when available. FDG PET scans seem to be superior in patients with SDH mutations, and FDOPA scans are superior in non-SDH mutations.<xref ref-type="bibr" rid="article-128632.r50">[50]</xref>&#x000a0;FDA or FDG PET would be preferable for staging paragangliomas with RET mutations.<xref ref-type="bibr" rid="article-128632.r51">[51]</xref>&#x000a0;Alternatively, Gallium DOTATATE can be used with high accuracy to stage SDH-related paragangliomas located in the head and neck region. Some reports have also suggested the overall superior sensitivity on a lesional basis in paragangliomas in general.<xref ref-type="bibr" rid="article-128632.r50">[50]</xref><xref ref-type="bibr" rid="article-128632.r52">[52]</xref><xref ref-type="bibr" rid="article-128632.r48">[48]</xref>&#x000a0;In Pheochromocytomas, FDOPA and FDG are superior. Considering the heterogeneity of disease and lesions and considering the Theranostic paradigm using different radiotracers in the same patient may hold additional value.<xref ref-type="bibr" rid="article-128632.r53">[53]</xref><xref ref-type="bibr" rid="article-128632.r54">[54]</xref><xref ref-type="bibr" rid="article-128632.r52">[52]</xref><xref ref-type="bibr" rid="article-128632.r55">[55]</xref>&#x000a0;MFBG, a newer PET analog to MIBG, demonstrates superior sensitivity and accuracy to the traditional SPECT MIBG scans with about twice the amount of lesions detected.<xref ref-type="bibr" rid="article-128632.r46">[46]</xref><xref ref-type="bibr" rid="article-128632.r56">[56]</xref><xref ref-type="bibr" rid="article-128632.r57">[57]</xref>&#x000a0;Further larger studies with pooled data from multiple centers are necessary to further elucidate the preferred radiopharmaceutical in a complex mutational landscape.</p>
          </list-item>
          <list-item>
            <p><bold>Miscellaneous tumors: </bold>FDG PET scans are proven to be highly accurate in staging and restaging gastrointestinal stromal tumors and mixed germ cell tumors.<xref ref-type="bibr" rid="article-128632.r58">[58]</xref><xref ref-type="bibr" rid="article-128632.r59">[59]</xref><xref ref-type="bibr" rid="article-128632.r60">[60]</xref><xref ref-type="bibr" rid="article-128632.r61">[61]</xref><xref ref-type="bibr" rid="article-128632.r62">[62]</xref><xref ref-type="bibr" rid="article-128632.r63">[63]</xref>&#x000a0;On the other hand, neuroendocrine tumors and insulinomas are easily characterized and staged with Gallium DOTATATE.<xref ref-type="bibr" rid="article-128632.r64">[64]</xref><xref ref-type="bibr" rid="article-128632.r65">[65]</xref><xref ref-type="bibr" rid="article-128632.r66">[66]</xref><xref ref-type="bibr" rid="article-128632.r67">[67]</xref>&#x000a0;Note should be made that Gallium DOTATATE could be&#x000a0;most of the time interchangeable with other similar Gallium&#x000a0;DOTANOC, DOTATOC, or copper-based somatostatin receptor-based ligands.</p>
          </list-item>
          <list-item>
            <p><bold>Thyroid cancer:&#x000a0;</bold>Thyroid cancer is uncommon in children compared to adults. Papillary thyroid cancer is the most common type. Although locoregional lymph node and distant metastasis&#x000a0;are more frequent&#x000a0;than in adults, the prognosis is significantly better, and survival rates are extremely high even with distant metastasis with appropriate treatment.<xref ref-type="bibr" rid="article-128632.r68">[68]</xref>&#x000a0;Iodine scans with or without SPECT-CT and ultrasound are the standard imaging techniques.<xref ref-type="bibr" rid="article-128632.r69">[69]</xref><xref ref-type="bibr" rid="article-128632.r70">[70]</xref><xref ref-type="bibr" rid="article-128632.r71">[71]</xref><xref ref-type="bibr" rid="article-128632.r72">[72]</xref>&#x000a0;The non-iodine avid disease can be imaged successfully with FDG PET.<xref ref-type="bibr" rid="article-128632.r73">[73]</xref><xref ref-type="bibr" rid="article-128632.r74">[74]</xref><xref ref-type="bibr" rid="article-128632.r75">[75]</xref>&#x000a0;Medullary thyroid cancer is rare but is best served by using FDOPA PET for staging and restaging when calcitonin levels are higher than 100 pg/ml.<xref ref-type="bibr" rid="article-128632.r74">[74]</xref><xref ref-type="bibr" rid="article-128632.r76">[76]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Congenital hypothyroidism: </bold>Pertechnetetate scan is a fairly simple exam to perform. It can pretty accurately distinguish between several etiologies: athyrogenesis (no thyroid uptake), ectopic thyroid/lingual thyroid (uptake is noted outside the expected thyroid bed/lower neck), and thyroid hormone dysgenesis (normal thyroidal uptake).&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Hyperparathyroidism: </bold>Hyperparathyroidism<bold>&#x000a0;</bold>is rarely encountered in pediatrics and can be evaluated by a sestamibi scan. It can localize parathyroid adenomas. Precise localization in a eutopic or ectopic location can be obtained using hybrid imaging techniques.</p>
          </list-item>
          <list-item>
            <p><bold>Chronic urinary tract infections and kidney scarring: </bold>DMSA scan with planar and SPECT imaging is the most sensitive technique&#x000a0;currently available for clinical use to evaluate kidney scarring.<xref ref-type="bibr" rid="article-128632.r77">[77]</xref><xref ref-type="bibr" rid="article-128632.r78">[78]</xref><xref ref-type="bibr" rid="article-128632.r79">[79]</xref><xref ref-type="bibr" rid="article-128632.r80">[80]</xref><xref ref-type="bibr" rid="article-128632.r81">[81]</xref>&#x000a0;An initial&#x000a0;report with PSMA PET has been published,&#x000a0;although this is expensive and not widely available. PSMA PET is also not FDA-approved yet.</p>
          </list-item>
          <list-item>
            <p><bold>Vesicoureteral reflux and scarring: A&#x000a0;</bold>DMSA scan is also quite effective in detecting renal scarring in patients with vesicoureteral reflux.<xref ref-type="bibr" rid="article-128632.r82">[82]</xref><xref ref-type="bibr" rid="article-128632.r83">[83]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Obstructive uropathies:&#x000a0;</bold>Ultrasound is the imaging of choice for patients' initial evaluation and follow-up with suspicion of obstructive uropathy. However, diuretic renograms are frequently used to confirm an obstruction and risk-stratify dilated collecting systems.<xref ref-type="bibr" rid="article-128632.r84">[84]</xref><xref ref-type="bibr" rid="article-128632.r85">[85]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Lymphodysplasias: </bold>Lymphoscintigrams<bold>&#x000a0;</bold>with&#x000a0;or without newer hybrid imaging SPECT-CT techniques are simple and accurate studies to evaluate abnormalities of the lymphatic system. It involves the intradermic, more or less subcutaneous injection of a colloid radiopharmaceutical. Indications&#x000a0;include congenital lymphodysplasias, lymphedema, lymphatic leaks, lymphangiomas, lymphangiomatosis, Gorham Stout disease, and lymphangiectasia.<xref ref-type="bibr" rid="article-128632.r86">[86]</xref><xref ref-type="bibr" rid="article-128632.r87">[87]</xref><xref ref-type="bibr" rid="article-128632.r88">[88]</xref><xref ref-type="bibr" rid="article-128632.r89">[89]</xref><xref ref-type="bibr" rid="article-128632.r90">[90]</xref><xref ref-type="bibr" rid="article-128632.r91">[91]</xref>&#x000a0;It is also helpful in the evaluation of chyluria, chyloperitoneum, and chylothoraces.&#x000a0;Protein-losing enteropathies are more effectively evaluated using an HSA scan.<xref ref-type="bibr" rid="article-128632.r92">[92]</xref><xref ref-type="bibr" rid="article-128632.r93">[93]</xref><xref ref-type="bibr" rid="article-128632.r94">[94]</xref><xref ref-type="bibr" rid="article-128632.r95">[95]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Biliary atresia (BA): </bold>Biliary atresia is&#x000a0;deadly without early surgical intervention (Kasai procedure). Optimal outcomes occur when surgery is performed before 45 days of life. Delay in diagnosis can be accompanied by complications such as cirrhosis, portal hypertension, liver failure, a decrease in the success rate of the Kasai procedure, and even death. HIDA scans/hepatobiliary scans evaluate uptake in the liver as well as the hepatobiliary system. Radiopharmaceutical excretion into the bowel excludes BA. Proper preparation with phenobarbital 5-7 days before the scan is essential.<xref ref-type="bibr" rid="article-128632.r96">[96]</xref><xref ref-type="bibr" rid="article-128632.r97">[97]</xref><xref ref-type="bibr" rid="article-128632.r98">[98]</xref><xref ref-type="bibr" rid="article-128632.r99">[99]</xref><xref ref-type="bibr" rid="article-128632.r100">[100]</xref>&#x000a0;Jancelewicz et al. reported in a cohort of 212 babies (45 with BA)&#x000a0;that&#x000a0;a normal percutaneous cholangiogram, bowel excretion on a HIDA scan, and blood work variables consisting of a&#x000a0;GGT&#x000a0;&#x0003c;150U/L and conjugated bilirubin &#x0003c;2.5mg/dL excluded BA with a 100% sensitivity.<xref ref-type="bibr" rid="article-128632.r100">[100]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Myocardial perfusion:&#x000a0;</bold>Cardiac MRI, echocardiography, and cardiac CT are the mainstays of pediatric imaging. Anatomical information is essential in cardiac congenital anomalies. MRI is nowadays able to provide reproducible stress-induced functional parameters. However, nuclear medicine myocardial perfusion imaging can still be used as a problem-solving tool. It is seldom needed but can be helpful to evaluate for ischemia and&#x000a0;risk stratify patients alone or in combination with MR. Common indications are congenital heart disease repair,&#x000a0;Kawasaki disease, hypoplastic heart, anomalous origin of the coronaries, coronary bridging, cardiac transplants, and other cardiomyopathies. SPECT or PET can be used with pharmacological stress. Although PET offers the advantage&#x000a0;of absolute myocardial blood flow quantification, this should be used with caution, and proper expertise in children should be sought as normal values are quite different and higher compared to adults.<xref ref-type="bibr" rid="article-128632.r101">[101]</xref><xref ref-type="bibr" rid="article-128632.r102">[102]</xref><xref ref-type="bibr" rid="article-128632.r103">[103]</xref><xref ref-type="bibr" rid="article-128632.r104">[104]</xref><xref ref-type="bibr" rid="article-128632.r105">[105]</xref><xref ref-type="bibr" rid="article-128632.r106">[106]</xref><xref ref-type="bibr" rid="article-128632.r107">[107]</xref><xref ref-type="bibr" rid="article-128632.r108">[108]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Meckel diverticulum:&#x000a0;</bold>Meckel scan is a simple and highly accurate test to evaluate Meckel diverticulum with a reported sensitivity and specificity in the mid-'90s.<xref ref-type="bibr" rid="article-128632.r109">[109]</xref>&#x000a0;In the few negative cases with high clinical suspicion, a repeat exam may have an additional value in detecting the Meckel's diverticulum.<xref ref-type="bibr" rid="article-128632.r110">[110]</xref>&#x000a0;The addition of novel hybrid imaging techniques with SPECT-CT can be, in some cases, of additional value.<xref ref-type="bibr" rid="article-128632.r111">[111]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Medically refractory epilepsy:&#x000a0;</bold>Nuclear medicine techniques are valuable in the presurgical workup of medically refractory epilepsy patients. Cerebral blood flow (CBF) SPECT and FDG PET imaging are essential exams to delineate the seizure onset zone (SOZ) required to be resected. Successful SOZ localization is needed for postsurgical seizure freedom. In patients with a clinical semiology amenable to CBF imaging, ictal-interictal subtraction offers accuracy in the '90s. Inter-ictal FDG PET imaging is also very useful in MRI negative cases to detect the SOZ. In MRI-positive cases, FDG PET delineation of the SOZ has also been reported to correlate with outcomes.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Encephalitis:&#x000a0;</bold>FDG PET is the most sensitive imaging technique to evaluate brain changes in encephalitis. It can also be used to monitor treatment response and metabolic brain changes in cases that later on develop epilepsy.<xref ref-type="bibr" rid="article-128632.r112">[112]</xref><xref ref-type="bibr" rid="article-128632.r113">[113]</xref><xref ref-type="bibr" rid="article-128632.r114">[114]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Brain tumors: </bold>MRI is the gold standard and workhorse of imaging in pediatric brain tumors. However, in some cases, MRI fails to fully characterize a lesion. Aminoacid imaging with C11-methionine, FDOPA, or FET PET can be used as a problem-solving tool in differentiating radiation necrosis changes versus recurrence in radiation treatment planning, defining the surgical extent, and guiding biopsies.<xref ref-type="bibr" rid="article-128632.r115">[115]</xref><xref ref-type="bibr" rid="article-128632.r116">[116]</xref><xref ref-type="bibr" rid="article-128632.r117">[117]</xref><xref ref-type="bibr" rid="article-128632.r118">[118]</xref><xref ref-type="bibr" rid="article-128632.r119">[119]</xref><xref ref-type="bibr" rid="article-128632.r120">[120]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Child abuse: </bold>Non-accidental injury in babies and children is a challenging clinical conundrum. Diagnosis is crucial, and a high suspicion should always be maintained. Bone scan offers a high sensitivity exam that adds value as an adjunct to the traditional skeletal survey.<xref ref-type="bibr" rid="article-128632.r121">[121]</xref><xref ref-type="bibr" rid="article-128632.r122">[122]</xref><xref ref-type="bibr" rid="article-128632.r123">[123]</xref><xref ref-type="bibr" rid="article-128632.r124">[124]</xref><xref ref-type="bibr" rid="article-128632.r125">[125]</xref><xref ref-type="bibr" rid="article-128632.r126">[126]</xref>&#x000a0;Bone scans can also be used in&#x000a0;additional&#x000a0;pathologies such as&#x000a0;sports injuries, scoliosis, trauma, back pain after surgery, osteoid osteoma, and Langerhans histiocytosis. Fluoride PET bone scans offer a high resolution and may replace the traditional bone SPECT scan when available.<xref ref-type="bibr" rid="article-128632.r127">[127]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Lung perfusion pathology:&#x000a0;</bold>Pulmonary artery anomalies and congenital cardiac malformations can be&#x000a0;evaluated with MAA scans. Lung perfusion can be evaluated before and after an intervention.<xref ref-type="bibr" rid="article-128632.r128">[128]</xref><xref ref-type="bibr" rid="article-128632.r129">[129]</xref><xref ref-type="bibr" rid="article-128632.r130">[130]</xref><xref ref-type="bibr" rid="article-128632.r131">[131]</xref>&#x000a0;Ventilation-perfusion scans can be used to assess unilateral hyperlucent lung.<xref ref-type="bibr" rid="article-128632.r132">[132]</xref><xref ref-type="bibr" rid="article-128632.r128">[128]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Gastrointestinal motility disorders: </bold>Delayed gastric emptying is frequently encountered in children. Solid or liquid-based gastric emptying studies can be used to assess gastric emptying.<xref ref-type="bibr" rid="article-128632.r133">[133]</xref><xref ref-type="bibr" rid="article-128632.r134">[134]</xref><xref ref-type="bibr" rid="article-128632.r135">[135]</xref><xref ref-type="bibr" rid="article-128632.r136">[136]</xref>&#x000a0;The solid-based protocol is the most sensitive and preferred when the child can tolerate eating solid foods. Otherwise, the liquid-based protocol is more frequently used as pediatric patients frequently have feeding tubes. The gastric emptying liquid is also used in babies and very young children.</p>
          </list-item>
          <list-item>
            <p><bold>Chronic microaspirations:&#x000a0;</bold>Patients with chronic microaspirations have frequent repeated pulmonary infections. Salivagrams are relatively easy nuclear medicine tests that require little preparation and can detect microaspirations.<xref ref-type="bibr" rid="article-128632.r137">[137]</xref><xref ref-type="bibr" rid="article-128632.r138">[138]</xref>&#x000a0;One drop of Technetium sulfur colloid or DTPA is administered on the tongue of the child/baby. Visualization of radiotracer accumulation in the lungs is consistent with aspiration. Using a technique administering 3 drops serially has a higher yield and sensitivity in detecting aspirations. Kim et al. showed that salivagrams and videofluoroscopic exams are complementary in detecting aspirations.<xref ref-type="bibr" rid="article-128632.r139">[139]</xref>&#x000a0;On the other hand, it showed that in 290 children, indwelling nasogastric tubes did not affect the positivity rate of salivagrams compared to pediatric patients without nasogastric tubes.<xref ref-type="bibr" rid="article-128632.r140">[140]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Gastroesophageal reflux:&#x000a0;</bold>In contrast to salivagrams, gastroesophageal reflux studies or milk scans are also&#x000a0;used to detect pulmonary aspiration. Jigang et al. compared both techniques in a cohort of 4186 patients and concluded that salivagrams have a much higher detection rate of 20.3% vs. 0.4% for gastroesophageal reflux studies.</p>
          </list-item>
          <list-item>
            <p><bold>Fever of unknown origin:&#x000a0;</bold>A variety of etiologies can be explored using FDG PET scans ranging from systemic inflammatory conditions, rheumatologic diseases/vasculidities, infectious processes, and oncology pathology.<xref ref-type="bibr" rid="article-128632.r141">[141]</xref><xref ref-type="bibr" rid="article-128632.r142">[142]</xref><xref ref-type="bibr" rid="article-128632.r143">[143]</xref><xref ref-type="bibr" rid="article-128632.r144">[144]</xref><xref ref-type="bibr" rid="article-128632.r145">[145]</xref><xref ref-type="bibr" rid="article-128632.r146">[146]</xref><xref ref-type="bibr" rid="article-128632.r147">[147]</xref>&#x000a0;Additionally, FDG PET scans are useful in evaluating conditions with increased inflammatory markers, even in the absence of fever. FDG PET scans can be used to evaluate response to therapies as well.</p>
          </list-item>
          <list-item>
            <p><bold>Evaluation of device infections:&#x000a0;</bold>FDG PET scans are used to&#x000a0;evaluate cardiovascular devices and implanted musculoskeletal hardware.<xref ref-type="bibr" rid="article-128632.r148">[148]</xref><xref ref-type="bibr" rid="article-128632.r149">[149]</xref><xref ref-type="bibr" rid="article-128632.r147">[147]</xref><xref ref-type="bibr" rid="article-128632.r150">[150]</xref><xref ref-type="bibr" rid="article-128632.r151">[151]</xref><xref ref-type="bibr" rid="article-128632.r152">[152]</xref>&#x000a0;They&#x000a0;have demonstrated very high sensitivity and specificity.<xref ref-type="bibr" rid="article-128632.r153">[153]</xref>&#x000a0;It has been shown to be superior to echocardiography and cardiac CT. It has also been shown to be prognostic and correlates well with outcomes.<xref ref-type="bibr" rid="article-128632.r154">[154]</xref><xref ref-type="bibr" rid="article-128632.r155">[155]</xref>&#x000a0;In contrast, white blood cell scans can also be used in the absence of FDG PET availability and, when used with hybrid imaging, SPECT-CT techniques offer high sensitivity, high specificity, and high reader confidence.<xref ref-type="bibr" rid="article-128632.r156">[156]</xref><xref ref-type="bibr" rid="article-128632.r157">[157]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-128632.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Pediatric nuclear medicine is a niche field and requires expertise for optimal outcomes. Appropriate use of nuclear medicine exams and their impact on clinical management obviates concerns about radiation exposure. Highly skilled experts such as child life specialists, pediatric anesthesia technologists, pediatric anesthesiologists, pediatric nuclear medicine technologists, pediatric nurses, and pediatric nuclear medicine physicians are needed.</p>
        <p>Proper communication and planning are essential. Following best medical practice and society guidelines is&#x000a0;paramount. Standardized, harmonized protocols must be followed. An integrated simple and advanced collaborative pathway and constant case discussions between the nuclear medicine team and referring pediatricians and pediatric subspecialists (in oncology, surgery, neurology, neurosurgery, urology, nephrology, rheumatology, gastroenterology, and orthopedics)&#x000a0;will&#x000a0;deliver&#x000a0;optimized outcomes. [Level 3, 4, and&#x000a0;5]</p>
      </sec>
      <sec id="article-128632.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=128632&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=128632">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/128632/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=128632">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-128632.s14">
        <fig id="article-128632.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Encephalitis FDG PET Contributed by Djekidel Mehdi MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Encephalitis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-128632.s15">
        <fig id="article-128632.image.f2" position="float" orientation="portrait">
          <caption>
            <p>FDOPA Brain Tumor Contributed by Djekidel Mehdi MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="FDOPA__Brain__Tumor" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-128632.s16">
        <fig id="article-128632.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Rasmussen Encephalitis Contributed by Djekidel Mehdi MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Rasmussen__encepahilitis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-128632.s17">
        <fig id="article-128632.image.f4" position="float" orientation="portrait">
          <caption>
            <p>TLE Epilepsy Contributed by Djekidel Mehdi MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="TLE__Hippocampus" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-128632.s18">
        <fig id="article-128632.image.f5" position="float" orientation="portrait">
          <caption>
            <p>DMSA scan in pediatrics Contributed by Mehdi Djekidel MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="DMSA__Scan" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-128632.s19">
        <title>References</title>
        <ref id="article-128632.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cherry</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Karp</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Qi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moses</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Badawi</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Total-Body PET: Maximizing Sensitivity to Create New Opportunities for Clinical Research and Patient Care.</article-title>
            <source>J Nucl Med</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-12</page-range>
            <pub-id pub-id-type="pmid">28935835</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vandenberghe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moskal</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Karp</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>State of the art in total body PET.</article-title>
            <source>EJNMMI Phys</source>
            <year>2020</year>
            <month>May</month>
            <day>25</day>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <pub-id pub-id-type="pmid">32451783</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Badawi</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Ding</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Nardo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cherry</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>First Human Imaging Studies with the EXPLORER Total-Body PET Scanner.</article-title>
            <source>J Nucl Med</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>60</volume>
            <issue>3</issue>
            <fpage>299</fpage>
            <page-range>299-303</page-range>
            <pub-id pub-id-type="pmid">30733314</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bellini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bonioli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Boccardo</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Lymphoscintigraphy in paediatric patients.</article-title>
            <source>Phlebology</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>24</volume>
            <issue>5</issue>
            <fpage>237; author reply 238</fpage>
            <pub-id pub-id-type="pmid">19767489</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Szuba</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Strauss</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Rockson</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema.</article-title>
            <source>J Nucl Med</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>44</volume>
            <issue>1</issue>
            <fpage>43</fpage>
            <page-range>43-57</page-range>
            <pub-id pub-id-type="pmid">12515876</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bellini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Boccardo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Campisi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Villa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Taddei</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Traggiai</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bonioli</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Lymphatic dysplasias in newborns and children: the role of lymphoscintigraphy.</article-title>
            <source>J Pediatr</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>152</volume>
            <issue>4</issue>
            <fpage>587</fpage>
            <page-range>587-9, 589.e1-3</page-range>
            <pub-id pub-id-type="pmid">18346521</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Expert Panel on Pediatric Imaging</collab>
              <name>
                <surname>Brown</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Simoneaux</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Dillman</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Rigsby</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Iyer</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Alazraki</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Bardo</surname>
                <given-names>DME</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Chandra</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dorfman</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Garber</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Shet</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Waseem</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Karmazyn</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>ACR Appropriateness Criteria&#x000ae; Antenatal Hydronephrosis-Infant.</article-title>
            <source>J Am Coll Radiol</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>17</volume>
            <issue>11S</issue>
            <fpage>S367</fpage>
            <page-range>S367-S379</page-range>
            <pub-id pub-id-type="pmid">33153550</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Cheon</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>WS</given-names>
              </name>
            </person-group>
            <article-title>Korean Society of Thyroid Radiology Guidelines for the Management of Pediatric Thyroid Nodules: Suitability and Risk Factors.</article-title>
            <source>Thyroid</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>31</volume>
            <issue>10</issue>
            <fpage>1472</fpage>
            <page-range>1472-1480</page-range>
            <pub-id pub-id-type="pmid">33832344</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vali</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Alessio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Balza</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Borgwardt</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bar-Sever</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Czachowski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jehanno</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kurch</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pandit-Taskar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Parisi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Piccardo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Seghers</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Shulkin</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Zucchetta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>SNMMI Procedure Standard/EANM Practice Guideline on Pediatric <sup>18</sup>F-FDG PET/CT for Oncology 1.0.</article-title>
            <source>J Nucl Med</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>62</volume>
            <issue>1</issue>
            <fpage>99</fpage>
            <page-range>99-110</page-range>
            <pub-id pub-id-type="pmid">33334912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Majd</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bar-Sever</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>De Palma</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The SNMMI and EANM Procedural Guidelines for Diuresis Renography in Infants and Children.</article-title>
            <source>J Nucl Med</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>59</volume>
            <issue>10</issue>
            <fpage>1636</fpage>
            <page-range>1636-1640</page-range>
            <pub-id pub-id-type="pmid">30275286</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Magill</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Alavi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Radiation Safety Concerns Related to PET/Computed Tomography Imaging for Assessing Pediatric Diseases and Disorders.</article-title>
            <source>PET Clin</source>
            <year>2020</year>
            <month>Jul</month>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>293</fpage>
            <page-range>293-298</page-range>
            <pub-id pub-id-type="pmid">32498985</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lassmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Treves</surname>
                <given-names>ST</given-names>
              </name>
              <collab>EANM/SNMMI Paediatric Dosage Harmonization Working Group</collab>
            </person-group>
            <article-title>Paediatric radiopharmaceutical administration: harmonization of the 2007 EANM paediatric dosage card (version 1.5.2008) and the 2010 North American consensus guidelines.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2014</year>
            <month>May</month>
            <volume>41</volume>
            <issue>5</issue>
            <fpage>1036</fpage>
            <page-range>1036-41</page-range>
            <pub-id pub-id-type="pmid">24599377</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fahey</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Ziniel</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Manion</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Treves</surname>
                <given-names>ST</given-names>
              </name>
            </person-group>
            <article-title>Administered Activities in Pediatric Nuclear Medicine and the Impact of the 2010 North American Consensus Guidelines on General Hospitals in the United States.</article-title>
            <source>J Nucl Med</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>57</volume>
            <issue>9</issue>
            <fpage>1478</fpage>
            <page-range>1478-85</page-range>
            <pub-id pub-id-type="pmid">27056617</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Treves</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Lassmann</surname>
                <given-names>M</given-names>
              </name>
              <collab>EANM/SNMMI Pediatric Dosage Harmonization Working Group</collab>
            </person-group>
            <article-title>International guidelines for pediatric radiopharmaceutical administered activities.</article-title>
            <source>J Nucl Med</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>55</volume>
            <issue>6</issue>
            <fpage>869</fpage>
            <page-range>869-70</page-range>
            <pub-id pub-id-type="pmid">24744446</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferrari</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Niccoli Asabella</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Merenda</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Altini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fanelli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Muggeo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>De Leonardis</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Perillo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Santoro</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rubini</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Pediatric Hodgkin Lymphoma: Predictive value of interim 18F-FDG PET/CT in therapy response assessment.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>96</volume>
            <issue>5</issue>
            <fpage>e5973</fpage>
            <pub-id pub-id-type="pmid">28151888</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bakhshi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Radhakrishnan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Thulkar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vishnubhatla</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dhawan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Malhotra</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pediatric nonlymphoblastic non-Hodgkin lymphoma: baseline, interim, and posttreatment PET/CT versus contrast-enhanced CT for evaluation--a prospective study.</article-title>
            <source>Radiology</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>262</volume>
            <issue>3</issue>
            <fpage>956</fpage>
            <page-range>956-68</page-range>
            <pub-id pub-id-type="pmid">22357895</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kluge</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wittig</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Georgi</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Kurch</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sabri</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Klekawka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-Teijeiro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ceppi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Karl&#x000e9;n</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pears</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cepelov&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Foss&#x000e5;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Beishuizen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hjalgrim</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>K&#x000f6;rholz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mauz-K&#x000f6;rholz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hasenclever</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Comparison of Interim PET Response to Second-Line Versus First-Line Treatment in Classic Hodgkin Lymphoma: Contribution to the Development of Response Criteria for Relapsed or Progressive Disease.</article-title>
            <source>J Nucl Med</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>62</volume>
            <issue>3</issue>
            <fpage>338</fpage>
            <page-range>338-341</page-range>
            <pub-id pub-id-type="pmid">32764122</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verhagen</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Menezes</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Neriman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Watson</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Punwani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Shankar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Daw</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Humphries</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title><sup>18</sup>F-FDG PET/MRI for Staging and Interim Response Assessment in Pediatric and Adolescent Hodgkin Lymphoma: A Prospective Study with <sup>18</sup>F-FDG PET/CT as the Reference Standard.</article-title>
            <source>J Nucl Med</source>
            <year>2021</year>
            <month>Nov</month>
            <volume>62</volume>
            <issue>11</issue>
            <fpage>1524</fpage>
            <page-range>1524-1530</page-range>
            <pub-id pub-id-type="pmid">33608429</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ingley</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Nadel</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Potts</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Eftekhari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Deyell</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>The Utility of PET/CT in Guiding Radiotherapy Reduction for Children With Hodgkin Lymphoma Treated With ABVD.</article-title>
            <source>J Pediatr Hematol Oncol</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>42</volume>
            <issue>2</issue>
            <fpage>e87</fpage>
            <page-range>e87-e93</page-range>
            <pub-id pub-id-type="pmid">31259825</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rahman</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>El Semary</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kenaai</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Omar</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zaky</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Nagy</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Can FDG-PET replace biopsy for the evaluation of residual tumor in pediatric mature B-cell non-Hodgkin lymphoma?</article-title>
            <source>Pediatr Blood Cancer</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>67</volume>
            <issue>9</issue>
            <fpage>e28310</fpage>
            <pub-id pub-id-type="pmid">32634295</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yin</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Metabolic tumor burden on baseline <sup>18</sup>F-FDG PET/CT improves risk stratification in pediatric patients with mature B-cell lymphoma.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>46</volume>
            <issue>9</issue>
            <fpage>1830</fpage>
            <page-range>1830-1839</page-range>
            <pub-id pub-id-type="pmid">31187163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>PET/CT predicts bone marrow involvement in paediatric non-Hodgkin lymphoma and may preclude the need for bone marrow biopsy in selected patients.</article-title>
            <source>Eur Radiol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>28</volume>
            <issue>7</issue>
            <fpage>2942</fpage>
            <page-range>2942-2950</page-range>
            <pub-id pub-id-type="pmid">29383519</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhojwani</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>McCarville</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Sawyer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Metzger</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Inaba</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Davidoff</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Gold</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shulkin</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Sandlund</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma.</article-title>
            <source>Br J Haematol</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>168</volume>
            <issue>6</issue>
            <fpage>845</fpage>
            <page-range>845-53</page-range>
            <pub-id pub-id-type="pmid">25382494</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Polverari</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ceci</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Passera</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Crane</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fanti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bernthal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Eilber</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Allen-Auerbach</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Czernin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Calais</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Federman</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>[<sup>18</sup>F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial.</article-title>
            <source>EJNMMI Res</source>
            <year>2020</year>
            <month>Oct</month>
            <day>15</day>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>122</fpage>
            <pub-id pub-id-type="pmid">33063147</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Donner</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Feraco</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Meneghello</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rombi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Picori</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chierichetti</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Usefulness of 18f-FDG PET-CT in Staging, Restaging, and Response Assessment in Pediatric Rhabdomyosarcoma.</article-title>
            <source>Diagnostics (Basel)</source>
            <year>2020</year>
            <month>Dec</month>
            <day>21</day>
            <volume>10</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">33371506</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harrison</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Chi</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hingorani</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mascarenhas</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>McCowage</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Weigel</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Venkatramani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wolden</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Yock</surname>
                <given-names>TI</given-names>
              </name>
              <name>
                <surname>Rodeberg</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Hayes-Jordan</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Teot</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Spunt</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Hawkins</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Shulkin</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Parisi</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Metabolic response as assessed by <sup>18</sup> F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.</article-title>
            <source>Cancer Med</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>857</fpage>
            <page-range>857-866</page-range>
            <pub-id pub-id-type="pmid">33340280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El-Hennawy</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Moustafa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Omar</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Elkinaai</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kamel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zaki</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Farid</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>El-Kholy</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Different <sup>18</sup> F-FDG PET parameters for the prediction of histological response to neoadjuvant chemotherapy in pediatric Ewing sarcoma family of tumors.</article-title>
            <source>Pediatr Blood Cancer</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>67</volume>
            <issue>11</issue>
            <fpage>e28605</fpage>
            <pub-id pub-id-type="pmid">32706520</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elmanzalawy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vali</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chavhan</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Omarkhail</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Amirabadi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shammas</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The impact of <sup>18</sup>F-FDG PET on initial staging and therapy planning of pediatric soft-tissue sarcoma patients.</article-title>
            <source>Pediatr Radiol</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>50</volume>
            <issue>2</issue>
            <fpage>252</fpage>
            <page-range>252-260</page-range>
            <pub-id pub-id-type="pmid">31628508</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmidkonz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Krumbholz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Atzinger</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cordes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goetz</surname>
                <given-names>TI</given-names>
              </name>
              <name>
                <surname>Prante</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Ritt</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Schaefer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Agaimy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hartmann</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>R&#x000f6;ssig</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fr&#x000f6;hlich</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>B&#x000e4;uerle</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dirksen</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kuwert</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Metzler</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from <sup>18</sup>F-FDG-PET/CT and circulating tumor DNA.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>47</volume>
            <issue>6</issue>
            <fpage>1564</fpage>
            <page-range>1564-1575</page-range>
            <pub-id pub-id-type="pmid">31853559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El-Kholy</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>El Nadi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hafez</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Younes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>El-Kenanii</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Khalid</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Added predictive value of 18F-FDG PET/CT for pediatric rhabdomyosarcoma.</article-title>
            <source>Nucl Med Commun</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>40</volume>
            <issue>9</issue>
            <fpage>898</fpage>
            <page-range>898-904</page-range>
            <pub-id pub-id-type="pmid">31145205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Albano</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dondi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Schumacher</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>D'Ippolito</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Porta</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Giubbini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bertagna</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Clinical and Prognostic Role of 18F-FDG PET/CT in Pediatric Ewing Sarcoma.</article-title>
            <source>J Pediatr Hematol Oncol</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>42</volume>
            <issue>2</issue>
            <fpage>e79</fpage>
            <page-range>e79-e86</page-range>
            <pub-id pub-id-type="pmid">31135716</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jiang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stanke</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lahti</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>The connections between neural crest development and neuroblastoma.</article-title>
            <source>Curr Top Dev Biol</source>
            <year>2011</year>
            <volume>94</volume>
            <fpage>77</fpage>
            <page-range>77-127</page-range>
            <pub-id pub-id-type="pmid">21295685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vik</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Pfluger</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kadota</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Castel</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tulchinsky</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Farto</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Heiba</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Serafini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tumeh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khutoryansky</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Jacobson</surname>
                <given-names>AF</given-names>
              </name>
            </person-group>
            <article-title>(123)I-mIBG scintigraphy in patients with known or suspected neuroblastoma: Results from a prospective multicenter trial.</article-title>
            <source>Pediatr Blood Cancer</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>52</volume>
            <issue>7</issue>
            <fpage>784</fpage>
            <page-range>784-90</page-range>
            <pub-id pub-id-type="pmid">19185008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kitamura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Baba</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Isoda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Maruoka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sasaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kamitani</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Koga</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kawakubo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Matsuura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ishigami</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title><sup>123</sup>I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis.</article-title>
            <source>Ann Nucl Med</source>
            <year>2021</year>
            <month>May</month>
            <volume>35</volume>
            <issue>5</issue>
            <fpage>549</fpage>
            <page-range>549-556</page-range>
            <pub-id pub-id-type="pmid">33586098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Piccardo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Morana</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Puntoni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Campora</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sorrentino</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zucchetta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ugolini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Conte</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cistaro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ferrarazzo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pescetto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lattuada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bottoni</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Garaventa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Giovanella</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lopci</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis, Treatment Response, and Prognosis: The Role of <sup>18</sup>F-DOPA PET/CT in Children Affected by Neuroblastoma in Comparison with <sup>123</sup>I-mIBG Scan: The First Prospective Study.</article-title>
            <source>J Nucl Med</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>61</volume>
            <issue>3</issue>
            <fpage>367</fpage>
            <page-range>367-374</page-range>
            <pub-id pub-id-type="pmid">31541036</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aboian</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Hernandez-Pampaloni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hawkins</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>VanBrocklin</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Huh</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Vo</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Gustafson</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Matthay</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title><sup>124</sup>I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed Neuroblastoma.</article-title>
            <source>J Nucl Med</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>62</volume>
            <issue>1</issue>
            <fpage>43</fpage>
            <page-range>43-47</page-range>
            <pub-id pub-id-type="pmid">32414950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cistaro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Quartuccio</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Caobelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Piccardo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Paratore</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Coppolino</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sperandeo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Arnone</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ficola</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>124I-MIBG: a new promising positron-emitting radiopharmaceutical for the evaluation of neuroblastoma.</article-title>
            <source>Nucl Med Rev Cent East Eur</source>
            <year>2015</year>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>102</fpage>
            <page-range>102-6</page-range>
            <pub-id pub-id-type="pmid">26315872</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maaz</surname>
                <given-names>AUR</given-names>
              </name>
              <name>
                <surname>O'Doherty</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Djekidel</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title><sup>68</sup>Ga-DOTATATE PET/CT for Neuroblastoma Staging: Utility for Clinical Use.</article-title>
            <source>J Nucl Med Technol</source>
            <year>2021</year>
            <month>Sep</month>
            <volume>49</volume>
            <issue>3</issue>
            <fpage>265</fpage>
            <page-range>265-268</page-range>
            <pub-id pub-id-type="pmid">33820858</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Telli</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lay Erg&#x000fc;n</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Volkan Salanci</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>&#x000d6;zgen Kiratli</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The Complementary Role of 68Ga-DOTATATE PET/CT in Neuroblastoma.</article-title>
            <source>Clin Nucl Med</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>45</volume>
            <issue>4</issue>
            <fpage>326</fpage>
            <page-range>326-329</page-range>
            <pub-id pub-id-type="pmid">31977455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marsh</surname>
                <given-names>IR</given-names>
              </name>
              <name>
                <surname>Grudzinski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Baiu</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Besemer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hernandez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jeffery</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Weichert</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Otto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bednarz</surname>
                <given-names>BP</given-names>
              </name>
            </person-group>
            <article-title>Preclinical Pharmacokinetics and Dosimetry Studies of <sup>124</sup>I/<sup>131</sup>I-CLR1404 for Treatment of Pediatric Solid Tumors in Murine Xenograft Models.</article-title>
            <source>J Nucl Med</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>60</volume>
            <issue>10</issue>
            <fpage>1414</fpage>
            <page-range>1414-1420</page-range>
            <pub-id pub-id-type="pmid">30926646</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Wahnishe</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sayre</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Hernandez-Pampaloni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hawkins</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Dannoon</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>VanBrocklin</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Itsara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Haas-Kogan</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Matthay</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET.</article-title>
            <source>Med Phys</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>37</volume>
            <issue>9</issue>
            <fpage>4861</fpage>
            <page-range>4861-7</page-range>
            <pub-id pub-id-type="pmid">20964203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Man</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>Q</given-names>
              </name>
            </person-group>
            <article-title>Value of pretreatment 18F-FDG PET/CT in prognosis and the reflection of tumor burden: a study in pediatric patients with newly diagnosed neuroblastoma.</article-title>
            <source>Int J Med Sci</source>
            <year>2021</year>
            <volume>18</volume>
            <issue>8</issue>
            <fpage>1857</fpage>
            <page-range>1857-1865</page-range>
            <pub-id pub-id-type="pmid">33746603</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sung</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Sharp</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Trout</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>Prognostic significance of pretreatment <sup>18</sup>F-FDG positron emission tomography/computed tomography in pediatric neuroblastoma.</article-title>
            <source>Pediatr Radiol</source>
            <year>2021</year>
            <month>Jul</month>
            <volume>51</volume>
            <issue>8</issue>
            <fpage>1400</fpage>
            <page-range>1400-1405</page-range>
            <pub-id pub-id-type="pmid">33629142</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dadgar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Norouzbeigi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ahmadzadehfar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Assadi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>68Ga-DOTATATE and 18F-FDG PET/CT for the Management of Esthesioneuroblastoma of the Sphenoclival Region.</article-title>
            <source>Clin Nucl Med</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>45</volume>
            <issue>8</issue>
            <fpage>e363</fpage>
            <page-range>e363-e364</page-range>
            <pub-id pub-id-type="pmid">32558717</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gains</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Aldridge</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Mattoli</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Bomanji</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Biassoni</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shankar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gaze</surname>
                <given-names>MN</given-names>
              </name>
            </person-group>
            <article-title>68Ga-DOTATATE and 123I-mIBG as imaging biomarkers of disease localisation in metastatic neuroblastoma: implications for molecular radiotherapy.</article-title>
            <source>Nucl Med Commun</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>41</volume>
            <issue>11</issue>
            <fpage>1169</fpage>
            <page-range>1169-1177</page-range>
            <pub-id pub-id-type="pmid">32796449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pauwels</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Celen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vandamme</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Leysen</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Baete</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bechter</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Bex</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Serdons</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Van Laere</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bormans</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Deroose</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Improved resolution and sensitivity of [<sup>18</sup>F]MFBG PET compared with [<sup>123</sup>I]MIBG SPECT in a patient with a norepinephrine transporter-expressing tumour.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>313</fpage>
            <page-range>313-315</page-range>
            <pub-id pub-id-type="pmid">32385645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sippel</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>O'Dorisio</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Vinik</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Lloyd</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Pacak</surname>
                <given-names>K</given-names>
              </name>
              <collab>North American Neuroendocrine Tumor Society (NANETS)</collab>
            </person-group>
            <article-title>The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer.</article-title>
            <source>Pancreas</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>39</volume>
            <issue>6</issue>
            <fpage>775</fpage>
            <page-range>775-83</page-range>
            <pub-id pub-id-type="pmid">20664475</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ryder</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Love</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Duncan</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Pattison</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>PET detectives: Molecular imaging for phaeochromocytomas and paragangliomas in the genomics era.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2021</year>
            <month>Jul</month>
            <volume>95</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-28</page-range>
            <pub-id pub-id-type="pmid">33296100</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ta&#x000ef;eb</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hicks</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Hindi&#x000e9;</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Guillet</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Avram</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ghedini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Timmers</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Elojeimy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rubello</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Virgolini</surname>
                <given-names>IJ</given-names>
              </name>
              <name>
                <surname>Fanti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Balogova</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pandit-Taskar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pacak</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>46</volume>
            <issue>10</issue>
            <fpage>2112</fpage>
            <page-range>2112-2137</page-range>
            <pub-id pub-id-type="pmid">31254038</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ling</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Millo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Viana</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>FI</given-names>
              </name>
              <name>
                <surname>Herscovitch</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Ta&#x000ef;eb</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Metwalli</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Linehan</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Brofferio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stratakis</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Kebebew</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lodish</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Civelek</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Pacak</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Superiority of <sup>68</sup>Ga-DOTATATE over <sup>18</sup>F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx )-related pheochromocytoma and paraganglioma in the pediatric population.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2018</year>
            <month>May</month>
            <volume>45</volume>
            <issue>5</issue>
            <fpage>787</fpage>
            <page-range>787-797</page-range>
            <pub-id pub-id-type="pmid">29204718</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Timmers</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Carrasquillo</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Whatley</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ling</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Havekes</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Eisenhofer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Martiniova</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Pacak</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>94</volume>
            <issue>12</issue>
            <fpage>4757</fpage>
            <page-range>4757-67</page-range>
            <pub-id pub-id-type="pmid">19864450</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jaiswal</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Sarathi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Malhotra</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hira</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Patil</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Dalvi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Prakash</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lila</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Bandgar</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>The utility of <sup>68</sup>Ga-DOTATATE PET/CT in localizing primary/metastatic pheochromocytoma and paraganglioma in children and adolescents&#x000a0;- a single-center experience.</article-title>
            <source>J Pediatr Endocrinol Metab</source>
            <year>2021</year>
            <month>Jan</month>
            <day>27</day>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>109</fpage>
            <page-range>109-119</page-range>
            <pub-id pub-id-type="pmid">33180042</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jaiswal</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Sarathi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Memon</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Malhotra</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Verma</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sehemby</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Patil</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Jadhav</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lila</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Bandgar</surname>
                <given-names>TR</given-names>
              </name>
            </person-group>
            <article-title>177Lu-DOTATATE therapy in metastatic/inoperable pheochromocytoma-paraganglioma.</article-title>
            <source>Endocr Connect</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>9</volume>
            <issue>9</issue>
            <fpage>864</fpage>
            <page-range>864-873</page-range>
            <pub-id pub-id-type="pmid">32784267</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parghane</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Talole</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Basu</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title><sup>131</sup>I-MIBG negative progressive symptomatic metastatic paraganglioma: response and outcome with <sup>177</sup>Lu-DOTATATE peptide receptor radionuclide therapy.</article-title>
            <source>Ann Nucl Med</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>92</fpage>
            <page-range>92-101</page-range>
            <pub-id pub-id-type="pmid">33135123</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tena</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Jha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Taieb</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pacak</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Somatostatin Receptors and Analogs in Pheochromocytoma and Paraganglioma: Old Players in a New Precision Medicine World.</article-title>
            <source>Front Endocrinol (Lausanne)</source>
            <year>2021</year>
            <volume>12</volume>
            <fpage>625312</fpage>
            <pub-id pub-id-type="pmid">33854479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Turnock</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Turton</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Martins</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Chesler</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Gouverneur</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kramer-Marek</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title><sup>18</sup>F-meta-fluorobenzylguanidine (<sup>18</sup>F-mFBG) to monitor changes in norepinephrine transporter expression in response to therapeutic intervention in neuroblastoma models.</article-title>
            <source>Sci Rep</source>
            <year>2020</year>
            <month>Dec</month>
            <day>01</day>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>20918</fpage>
            <pub-id pub-id-type="pmid">33262374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pandit-Taskar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zanzonico</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Staton</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Carrasquillo</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Reidy-Lagunes</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lyashchenko</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Burnazi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Blasberg</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Larson</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Modak</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Biodistribution and Dosimetry of <sup>18</sup>F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies.</article-title>
            <source>J Nucl Med</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>147</fpage>
            <page-range>147-153</page-range>
            <pub-id pub-id-type="pmid">28705916</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hassanzadeh-Rad</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yousefifard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Katal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Asady</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fard-Esfahani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moghadas Jafari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hosseini</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The value of (18) F-fluorodeoxyglucose positron emission tomography for prediction of treatment response in gastrointestinal stromal tumors: a systematic review and meta-analysis.</article-title>
            <source>J Gastroenterol Hepatol</source>
            <year>2016</year>
            <month>May</month>
            <volume>31</volume>
            <issue>5</issue>
            <fpage>929</fpage>
            <page-range>929-35</page-range>
            <pub-id pub-id-type="pmid">26642423</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rasheed</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Al-Kandari</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ghanem</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marafi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Usmani</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Significance of 18F-FDG PET/CT in Characterization of Equivocal Lesions in High-Risk Testicular Carcinoma in Restaging Setting.</article-title>
            <source>Asian Pac J Cancer Prev</source>
            <year>2020</year>
            <month>Feb</month>
            <day>01</day>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>511</fpage>
            <page-range>511-515</page-range>
            <pub-id pub-id-type="pmid">32102532</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cook</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Sohaib</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Huddart</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Dearnaley</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Horwich</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chua</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The role of 18F-FDG PET/CT in the management of testicular cancers.</article-title>
            <source>Nucl Med Commun</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>36</volume>
            <issue>7</issue>
            <fpage>702</fpage>
            <page-range>702-8</page-range>
            <pub-id pub-id-type="pmid">25757201</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sanchez</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zudaire</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Fernandez</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Lopez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Arocena</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sanz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gimenez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rosell</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Robles</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Berian</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>18F-fluoro-2-deoxyglucose-positron emission tomography in the evaluation of nonseminomatous germ cell tumours at relapse.</article-title>
            <source>BJU Int</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>89</volume>
            <issue>9</issue>
            <fpage>912</fpage>
            <page-range>912-6</page-range>
            <pub-id pub-id-type="pmid">12010239</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hain</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>O'Doherty</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Timothy</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Leslie</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Partridge</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Huddart</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Fluorodeoxyglucose PET in the initial staging of germ cell tumours.</article-title>
            <source>Eur J Nucl Med</source>
            <year>2000</year>
            <month>May</month>
            <volume>27</volume>
            <issue>5</issue>
            <fpage>590</fpage>
            <page-range>590-4</page-range>
            <pub-id pub-id-type="pmid">10853816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Parida</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Karunanithi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thulkar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Julka</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Bal</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic accuracy of integrated (18)F-FDG PET/CT for restaging patients with malignant germ cell tumours.</article-title>
            <source>Br J Radiol</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>87</volume>
            <issue>1040</issue>
            <fpage>20140263</fpage>
            <pub-id pub-id-type="pmid">24896199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haddad</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fard-Esfahani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vali</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>A review of pediatric neuroendocrine tumors, their detection, and treatment by radioisotopes.</article-title>
            <source>Nucl Med Commun</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>42</volume>
            <issue>1</issue>
            <fpage>21</fpage>
            <page-range>21-31</page-range>
            <pub-id pub-id-type="pmid">33044400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Foster</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Sher</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Seghers</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Poston</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wells</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Delpassand</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Potter</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mahajan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Venkatramani</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Peptide receptor radionuclide therapy for treatment of metastatic neuroendocrine tumors in children.</article-title>
            <source>Pediatr Blood Cancer</source>
            <year>2021</year>
            <month>Jul</month>
            <volume>68</volume>
            <issue>7</issue>
            <fpage>e29056</fpage>
            <pub-id pub-id-type="pmid">33844446</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McElroy</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Binkovitz</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Trout</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Czachowski</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Seghers</surname>
                <given-names>VJ</given-names>
              </name>
              <name>
                <surname>Lteif</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>States</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Pediatric applications of Dotatate: early diagnostic and therapeutic experience.</article-title>
            <source>Pediatr Radiol</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>50</volume>
            <issue>7</issue>
            <fpage>882</fpage>
            <page-range>882-897</page-range>
            <pub-id pub-id-type="pmid">32495176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shukla</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bansal</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sodhi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marwaha</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Mittal</surname>
                <given-names>BR</given-names>
              </name>
            </person-group>
            <article-title>(68)Ga-DOTATATE positron emission tomography/computed tomography scan in the detection of bone metastases in pediatric neuroendocrine tumors.</article-title>
            <source>Indian J Nucl Med</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-7</page-range>
            <pub-id pub-id-type="pmid">24591776</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhavani</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bhadran</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Menon</surname>
                <given-names>UV</given-names>
              </name>
              <name>
                <surname>Pavithran</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Menon</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Abraham</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pankaj</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Treatment outcomes in pediatric differentiated thyroid carcinoma.</article-title>
            <source>J Pediatr Endocrinol Metab</source>
            <year>2018</year>
            <month>Oct</month>
            <day>25</day>
            <volume>31</volume>
            <issue>10</issue>
            <fpage>1117</fpage>
            <page-range>1117-1122</page-range>
            <pub-id pub-id-type="pmid">30157034</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pires</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Alves</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Bordallo</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Bulzico</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Lopes</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Farias</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dias</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lima</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Santos Gisler</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>Coeli</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Carvalhaes de Oliveira</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Corbo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vaisman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vaisman</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Prognostic Factors for Early and Long-Term Remission in Pediatric Differentiated Thyroid Carcinoma: The Role of Sex, Age, Clinical Presentation, and the Newly Proposed American Thyroid Association Risk Stratification System.</article-title>
            <source>Thyroid</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>26</volume>
            <issue>10</issue>
            <fpage>1480</fpage>
            <page-range>1480-1487</page-range>
            <pub-id pub-id-type="pmid">27540892</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zanella</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Scheffel</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Nava</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Golbert</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Laurini de Souza Meyer</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Punales</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gon&#x000e7;alves</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Dora</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Maia</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Dynamic Risk Stratification in the Follow-Up of Children and Adolescents with Differentiated Thyroid Cancer.</article-title>
            <source>Thyroid</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>28</volume>
            <issue>10</issue>
            <fpage>1285</fpage>
            <page-range>1285-1292</page-range>
            <pub-id pub-id-type="pmid">30129889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lazar</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lebenthal</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Segal</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Steinmetz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Strenov</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yaniv</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Yackobovitch-Gavan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Phillip</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pediatric Thyroid Cancer: Postoperative Classifications and Response to Initial Therapy as Prognostic Factors.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2016</year>
            <month>May</month>
            <volume>101</volume>
            <issue>5</issue>
            <fpage>1970</fpage>
            <page-range>1970-9</page-range>
            <pub-id pub-id-type="pmid">26930182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Livhits</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Pasternak</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Xiong</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gosnell</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Yeh</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Chiu</surname>
                <given-names>HK</given-names>
              </name>
            </person-group>
            <article-title>PRE-ABLATION THYROGLOBULIN AND THYROGLOBULIN TO THYROID-STIMULATING HORMONE RATIO MAY BE ASSOCIATED WITH PULMONARY METASTASES IN CHILDREN WITH DIFFERENTIATED THYROID CANCER.</article-title>
            <source>Endocr Pract</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>22</volume>
            <issue>11</issue>
            <fpage>1259</fpage>
            <page-range>1259-1266</page-range>
            <pub-id pub-id-type="pmid">27482611</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quinn</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mahmood</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Pandit-Taskar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Behr</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zanzonico</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dauer</surname>
                <given-names>LT</given-names>
              </name>
            </person-group>
            <article-title>Patient-adapted organ absorbed dose and effective dose estimates in pediatric 18F-FDG positron emission tomography/computed tomography studies.</article-title>
            <source>BMC Med Imaging</source>
            <year>2020</year>
            <month>Jan</month>
            <day>29</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <pub-id pub-id-type="pmid">31996149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zampella</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Klain</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pace</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cuocolo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>PET/CT in the management of differentiated thyroid cancer.</article-title>
            <source>Diagn Interv Imaging</source>
            <year>2021</year>
            <month>Sep</month>
            <volume>102</volume>
            <issue>9</issue>
            <fpage>515</fpage>
            <page-range>515-523</page-range>
            <pub-id pub-id-type="pmid">33926848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okuyucu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ince</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Alagoz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Emer</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>San</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Balkan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ayan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Meric</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Haymana</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ac&#x00131;kel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gunalp</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Karacalioglu</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Arslan</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging <sup>18</sup>F-FDG PET/CT.</article-title>
            <source>Hell J Nucl Med</source>
            <year>2016</year>
            <season>Sep-Dec</season>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>208</fpage>
            <page-range>208-217</page-range>
            <pub-id pub-id-type="pmid">27824959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castinetti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ta&#x000ef;eb</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Positron Emission Tomography Imaging in Medullary Thyroid Carcinoma: Time for Reappraisal?</article-title>
            <source>Thyroid</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>151</fpage>
            <page-range>151-155</page-range>
            <pub-id pub-id-type="pmid">33191866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarikaya</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sarikaya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Current Status of Radionuclide Renal Cortical Imaging in Pyelonephritis.</article-title>
            <source>J Nucl Med Technol</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>47</volume>
            <issue>4</issue>
            <fpage>309</fpage>
            <page-range>309-312</page-range>
            <pub-id pub-id-type="pmid">31182659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shaikh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shope</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Hoberman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Muniz</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Bhatnagar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nowalk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hickey</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Michaels</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Kearney</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rockette</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Charron</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Majd</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shalaby-Rana</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kurs-Lasky</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Wald</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Lockhart</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pohl</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Corticosteroids to prevent kidney scarring in children with a febrile urinary tract infection: a randomized trial.</article-title>
            <source>Pediatr Nephrol</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>35</volume>
            <issue>11</issue>
            <fpage>2113</fpage>
            <page-range>2113-2120</page-range>
            <pub-id pub-id-type="pmid">32556960</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Einarsd&#x000f3;ttir</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>RMG</given-names>
              </name>
              <name>
                <surname>Borgwardt</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Interrater Reliability of <sup>99m</sup>Tc-DMSA Scintigraphy Performed as Planar Scan vs. SPECT/Low Dose CT for Diagnosing Renal Scarring in Children.</article-title>
            <source>Diagnostics (Basel)</source>
            <year>2020</year>
            <month>Dec</month>
            <day>17</day>
            <volume>10</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">33348530</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ozen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ertan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Aras</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gumuser</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ozkol</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Horasan Dinc</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of abnormal radiological findings in children aged 2 to 36 months followed by recurrent urinary tract infection: a retrospective study.</article-title>
            <source>Ren Fail</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>100</fpage>
            <page-range>100-103</page-range>
            <pub-id pub-id-type="pmid">27819162</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roupakias</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sinopidis</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Tsikopoulos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Spyridakis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Karatza</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Varvarigou</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Dimercaptosuccinic acid scan challenges in childhood urinary tract infection, vesicoureteral reflux and renal scarring investigation and management.</article-title>
            <source>Minerva Urol Nefrol</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>69</volume>
            <issue>2</issue>
            <fpage>144</fpage>
            <page-range>144-152</page-range>
            <pub-id pub-id-type="pmid">27355216</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Breinbjerg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>J&#x000f8;rgensen</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Fr&#x000f8;ki&#x000e6;r</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tullus</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kamperis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rittig</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Risk factors for kidney scarring and vesicoureteral reflux in 421 children after their first acute pyelonephritis, and appraisal of international guidelines.</article-title>
            <source>Pediatr Nephrol</source>
            <year>2021</year>
            <month>Sep</month>
            <volume>36</volume>
            <issue>9</issue>
            <fpage>2777</fpage>
            <page-range>2777-2787</page-range>
            <pub-id pub-id-type="pmid">33754234</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arapovi&#x00107;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Punda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brdar</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>&#x0010c;apkun</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bajo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Velja&#x0010d;i&#x00107;</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Punda</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Simi&#x0010d;i&#x00107;-Majce</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saraga-Babi&#x00107;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vukojevi&#x00107;</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Saraga</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Types of Parenchymal Changes Diagnosed on DMSA Scans of Kidneys Affected by Different Grades of Vesicoureteral Reflux.</article-title>
            <source>Med Sci Monit</source>
            <year>2021</year>
            <month>Mar</month>
            <day>01</day>
            <volume>27</volume>
            <fpage>e929617</fpage>
            <pub-id pub-id-type="pmid">33647007</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Jeong</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Ha</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Predictive value of cortical transit time on MAG3 for surgery in antenatally detected unilateral hydronephrosis caused by ureteropelvic junction stenosis.</article-title>
            <source>J Pediatr Urol</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>55.e1</fpage>
            <page-range>55.e1-55.e6</page-range>
            <pub-id pub-id-type="pmid">28988673</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Faure</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>London</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>GH</given-names>
              </name>
            </person-group>
            <article-title>Early mercaptoacetyltriglycine(MAG-3) diuretic renography results after pyeloplasty.</article-title>
            <source>BJU Int</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>118</volume>
            <issue>5</issue>
            <fpage>790</fpage>
            <page-range>790-796</page-range>
            <pub-id pub-id-type="pmid">27105017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pui</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Yueh</surname>
                <given-names>TC</given-names>
              </name>
            </person-group>
            <article-title>Lymphoscintigraphy in chyluria, chyloperitoneum and chylothorax.</article-title>
            <source>J Nucl Med</source>
            <year>1998</year>
            <month>Jul</month>
            <volume>39</volume>
            <issue>7</issue>
            <fpage>1292</fpage>
            <page-range>1292-6</page-range>
            <pub-id pub-id-type="pmid">9669413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Turpin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lambert</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Lymphoscintigraphy of Chylous Anomalies: Chylothorax, Chyloperitoneum, Chyluria, and Lymphangiomatosis-15-Year Experience in a Pediatric Setting and Review of the Literature.</article-title>
            <source>J Nucl Med Technol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>46</volume>
            <issue>2</issue>
            <fpage>123</fpage>
            <page-range>123-128</page-range>
            <pub-id pub-id-type="pmid">29438003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bellini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Villa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sambuceti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Traggiai</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Campisi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bellini</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Morcaldi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Massocco</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bonioli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Boccardo</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Lymphoscintigraphy patterns in newborns and children with congenital lymphatic dysplasia.</article-title>
            <source>Lymphology</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>47</volume>
            <issue>1</issue>
            <fpage>28</fpage>
            <page-range>28-39</page-range>
            <pub-id pub-id-type="pmid">25109167</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Watt</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Singh-Grewal</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wargon</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Paediatric lymphoedema: A retrospective chart review of 86 cases.</article-title>
            <source>J Paediatr Child Health</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>53</volume>
            <issue>1</issue>
            <fpage>38</fpage>
            <page-range>38-42</page-range>
            <pub-id pub-id-type="pmid">27701785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuo</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Barber</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Kylat</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Klewer</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Behan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lau-Braunhut</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bernas</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Moedano</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bedrick</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Mustacich</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Witte</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Whole-body lymphangioscintigraphy and SPECT/CT in children with lymphatic complications after surgery for complex congenital heart disease.</article-title>
            <source>Lymphology</source>
            <year>2019</year>
            <volume>52</volume>
            <issue>4</issue>
            <fpage>157</fpage>
            <page-range>157-165</page-range>
            <pub-id pub-id-type="pmid">32171182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jing</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Usefulness of 99mTc-ASC lymphoscintigraphy and SPECT/CT in the evaluation of rare lymphatic disorders: Gorham-Stout disease, lymphangioma, and lymphangioleiomyomatosis.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2020</year>
            <month>Sep</month>
            <day>25</day>
            <volume>99</volume>
            <issue>39</issue>
            <fpage>e22414</fpage>
            <pub-id pub-id-type="pmid">32991473</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Law</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>KK</given-names>
              </name>
            </person-group>
            <article-title>The clinical characteristics of lupus related protein-losing enteropathy in Hong Kong Chinese population: 10 years of experience from a regional hospital.</article-title>
            <source>Lupus</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>21</volume>
            <issue>8</issue>
            <fpage>840</fpage>
            <page-range>840-7</page-range>
            <pub-id pub-id-type="pmid">22343095</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chau</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Mok</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Luk</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>FT</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of performance of measurement of faecal &#x003b1;(1)-antitrypsin clearance and technetium-99m human serum albumin scintigraphy in protein-losing enteropathy.</article-title>
            <source>Digestion</source>
            <year>2011</year>
            <volume>84</volume>
            <issue>3</issue>
            <fpage>199</fpage>
            <page-range>199-206</page-range>
            <pub-id pub-id-type="pmid">21757911</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Halaby</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bakheet</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Shabib</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Powe</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Al Mehaidib</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nazer</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>99mTc-human serum albumin scans in children with protein-losing enteropathy.</article-title>
            <source>J Nucl Med</source>
            <year>2000</year>
            <month>Feb</month>
            <volume>41</volume>
            <issue>2</issue>
            <fpage>215</fpage>
            <page-range>215-9</page-range>
            <pub-id pub-id-type="pmid">10688102</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chiu</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>HS</given-names>
              </name>
            </person-group>
            <article-title>Protein-losing enteropathy: diagnosis with (99m)Tc-labeled human serum albumin scintigraphy.</article-title>
            <source>Radiology</source>
            <year>2001</year>
            <month>Apr</month>
            <volume>219</volume>
            <issue>1</issue>
            <fpage>86</fpage>
            <page-range>86-90</page-range>
            <pub-id pub-id-type="pmid">11274540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r96">
          <label>96</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Snyder</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kashyap</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lopez</surname>
                <given-names>PP</given-names>
              </name>
            </person-group>
            <chapter-title>Hepatobiliary Iminodiacetic Acid Scan</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>24</day>
            <pub-id pub-id-type="pmid">30969603</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stagg</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cameron</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jimenez-Rivera</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Yanchar</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Emil</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Anthopoulos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Schreiber</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Laberge</surname>
                <given-names>JM</given-names>
              </name>
              <collab>Canadian Biliary Atresia Registry</collab>
            </person-group>
            <article-title>Variability of diagnostic approach, surgical technique, and medical management for children with biliary atresia in Canada - Is it time for standardization?</article-title>
            <source>J Pediatr Surg</source>
            <year>2017</year>
            <month>May</month>
            <volume>52</volume>
            <issue>5</issue>
            <fpage>802</fpage>
            <page-range>802-806</page-range>
            <pub-id pub-id-type="pmid">28189446</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bhatnagar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rangarajan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Patankar</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Utility of Tc99m-Mebrofenin hepato-biliary scintigraphy (HIDA scan) for the diagnosis of biliary atresia.</article-title>
            <source>Trop Gastroenterol</source>
            <year>2012</year>
            <season>Jan-Mar</season>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>62</fpage>
            <page-range>62-4</page-range>
            <pub-id pub-id-type="pmid">22803298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Robie</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Overfelt</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Differentiating biliary atresia from other causes of cholestatic jaundice.</article-title>
            <source>Am Surg</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>80</volume>
            <issue>9</issue>
            <fpage>827</fpage>
            <page-range>827-31</page-range>
            <pub-id pub-id-type="pmid">25197861</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jancelewicz</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Barmherzig</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Ling</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Kamath</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Amaral</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fecteau</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Langer</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>A screening algorithm for the efficient exclusion of biliary atresia in infants with cholestatic jaundice.</article-title>
            <source>J Pediatr Surg</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>50</volume>
            <issue>3</issue>
            <fpage>363</fpage>
            <page-range>363-70</page-range>
            <pub-id pub-id-type="pmid">25746690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fares</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Critser</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Arruda</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Wilhelm</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Rattan</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Alsaied</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Pharmacologic stress cardiovascular magnetic resonance in the pediatric population: A review of the literature, proposed protocol, and two examples in patients with Kawasaki disease.</article-title>
            <source>Congenit Heart Dis</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>1166</fpage>
            <page-range>1166-1175</page-range>
            <pub-id pub-id-type="pmid">31498562</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doan</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Loar</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Pednekar</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Masand</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Noel</surname>
                <given-names>CV</given-names>
              </name>
            </person-group>
            <article-title>Regadenoson Stress Perfusion Cardiac Magnetic Resonance Imaging in Children With Kawasaki Disease and Coronary Artery Disease.</article-title>
            <source>Am J Cardiol</source>
            <year>2019</year>
            <month>Oct</month>
            <day>01</day>
            <volume>124</volume>
            <issue>7</issue>
            <fpage>1125</fpage>
            <page-range>1125-1132</page-range>
            <pub-id pub-id-type="pmid">31371063</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r103">
          <label>103</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abe</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tsuda</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sugiyama</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kiso</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Risk factors of non-sustained ventricular tachycardia by technetium-perfusion imaging in patients with coronary artery lesions caused by Kawasaki disease.</article-title>
            <source>J Cardiol</source>
            <year>2019</year>
            <month>May</month>
            <volume>73</volume>
            <issue>5</issue>
            <fpage>358</fpage>
            <page-range>358-362</page-range>
            <pub-id pub-id-type="pmid">30606680</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r104">
          <label>104</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vijarnsorn</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Noga</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schantz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pepelassis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tham</surname>
                <given-names>EB</given-names>
              </name>
            </person-group>
            <article-title>Stress perfusion magnetic resonance imaging to detect coronary artery lesions in children.</article-title>
            <source>Int J Cardiovasc Imaging</source>
            <year>2017</year>
            <month>May</month>
            <volume>33</volume>
            <issue>5</issue>
            <fpage>699</fpage>
            <page-range>699-709</page-range>
            <pub-id pub-id-type="pmid">28000002</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r105">
          <label>105</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kamiyama</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Karasawa</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>[Cardiac scintigraphy-Pharmacological stress and appropriate management of pediatric radiopharmaceutical administration in patients after Kawasaki disease].</article-title>
            <source>Nihon Rinsho</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>72</volume>
            <issue>9</issue>
            <fpage>1595</fpage>
            <page-range>1595-600</page-range>
            <pub-id pub-id-type="pmid">25518408</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r106">
          <label>106</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fukazawa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ogawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fukushima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kiriyama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hayashi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Itoh</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Usefulness of Single Photon Emission Computed Tomography/Computed Tomography Fusion-Hybrid Imaging to Evaluate Coronary Artery Disorders in Patients with a History of Kawasaki Disease.</article-title>
            <source>J Nippon Med Sch</source>
            <year>2016</year>
            <volume>83</volume>
            <issue>2</issue>
            <fpage>71</fpage>
            <page-range>71-80</page-range>
            <pub-id pub-id-type="pmid">27180792</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r107">
          <label>107</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doan</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Molossi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sachdeva</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Loar</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Weigand</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Schlingmann</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Reaves-O'Neal</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Pednekar</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Masand</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Noel</surname>
                <given-names>CV</given-names>
              </name>
            </person-group>
            <article-title>Dobutamine stress cardiac MRI is safe and feasible in pediatric patients with anomalous aortic origin of a coronary artery (AAOCA).</article-title>
            <source>Int J Cardiol</source>
            <year>2021</year>
            <month>Jul</month>
            <day>01</day>
            <volume>334</volume>
            <fpage>42</fpage>
            <page-range>42-48</page-range>
            <pub-id pub-id-type="pmid">33892043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r108">
          <label>108</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doan</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Zea-Vera</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Agrawal</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mery</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Masand</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Reaves-O'Neal</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Noel</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Qureshi</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Sexson-Tejtel</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Fraser</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Molossi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Myocardial Ischemia in Children With Anomalous Aortic Origin of a Coronary Artery With Intraseptal Course.</article-title>
            <source>Circ Cardiovasc Interv</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>e008375</fpage>
            <pub-id pub-id-type="pmid">32102565</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r109">
          <label>109</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sinha</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Pallewatte</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Easty</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>De Coppi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pierro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Misra</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Biassoni</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Meckel's scan in children: a review of 183 cases referred to two paediatric surgery specialist centres over 18 years.</article-title>
            <source>Pediatr Surg Int</source>
            <year>2013</year>
            <month>May</month>
            <volume>29</volume>
            <issue>5</issue>
            <fpage>511</fpage>
            <page-range>511-7</page-range>
            <pub-id pub-id-type="pmid">23417523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r110">
          <label>110</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vali</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Daneman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McQuattie</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shammas</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The value of repeat scintigraphy in patients with a high clinical suspicion for Meckel diverticulum after a negative or equivocal first Meckel scan.</article-title>
            <source>Pediatr Radiol</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>45</volume>
            <issue>10</issue>
            <fpage>1506</fpage>
            <page-range>1506-14</page-range>
            <pub-id pub-id-type="pmid">25846077</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r111">
          <label>111</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dillman</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Frey</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Strouse</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Utility of SPECT/CT with Meckel's scintigraphy.</article-title>
            <source>Ann Nucl Med</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>23</volume>
            <issue>9</issue>
            <fpage>813</fpage>
            <page-range>813-5</page-range>
            <pub-id pub-id-type="pmid">19784878</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r112">
          <label>112</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morbelli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Djekidel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hesse</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pagani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Barthel</surname>
                <given-names>H</given-names>
              </name>
              <collab>Neuroimaging Committee of the European Association of Nuclear Medicine (EANM)</collab>
              <collab>Brain Imaging Council of the Society of Nuclear Medicine and Molecular Imaging (SNMMI)</collab>
            </person-group>
            <article-title>Role of (18)F-FDG-PET imaging in the diagnosis of autoimmune encephalitis.</article-title>
            <source>Lancet Neurol</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>15</volume>
            <issue>10</issue>
            <fpage>1009</fpage>
            <page-range>1009-10</page-range>
            <pub-id pub-id-type="pmid">27571149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r113">
          <label>113</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morbelli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Arbizu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Booij</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Chetelat</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cross</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Djekidel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Drzezga</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ekmekcioglu</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Garibotto</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Hesse</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ishii</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jafari</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lammertsma</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Law</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mathews</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Minoshima</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mosci</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pagani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pappata</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Silverman</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Signore</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Van De Giessen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Villemagne</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Barthel</surname>
                <given-names>H</given-names>
              </name>
              <collab>European Association of Nuclear Medicine (EANM) and of the Society of Nuclear Medicine and Molecular Imaging (SNMMI)</collab>
            </person-group>
            <article-title>The need of standardization and of large clinical studies in an emerging indication of [<sup>18</sup>F]FDG PET: the autoimmune encephalitis.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>44</volume>
            <issue>3</issue>
            <fpage>353</fpage>
            <page-range>353-357</page-range>
            <pub-id pub-id-type="pmid">27924371</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r114">
          <label>114</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Djekidel</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title><sup>18</sup>F-FDG PET Imaging Predicts the Epileptogenic Zone Prospectively in Recurrent Cryptogenic Meningoencephalitis with Subsequent Simple Partial Visual Seizures.</article-title>
            <source>J Nucl Med Technol</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>49</volume>
            <issue>1</issue>
            <fpage>92</fpage>
            <page-range>92-94</page-range>
            <pub-id pub-id-type="pmid">33219155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r115">
          <label>115</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grosse</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wedel</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Thomale</surname>
                <given-names>UW</given-names>
              </name>
              <name>
                <surname>Steffen</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brenner</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Plotkin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Driever</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>Benefit of Static FET PET in Pretreated Pediatric Brain Tumor Patients with Equivocal Conventional MRI Results.</article-title>
            <source>Klin Padiatr</source>
            <year>2021</year>
            <month>May</month>
            <volume>233</volume>
            <issue>3</issue>
            <fpage>127</fpage>
            <page-range>127-134</page-range>
            <pub-id pub-id-type="pmid">33598897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r116">
          <label>116</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Somme</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bender</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Namer</surname>
                <given-names>IJ</given-names>
              </name>
              <name>
                <surname>No&#x000eb;l</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bund</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Usefulness of <sup>18</sup>F-FDOPA PET for the management of primary brain tumors: a systematic review of the literature.</article-title>
            <source>Cancer Imaging</source>
            <year>2020</year>
            <month>Oct</month>
            <day>06</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>70</fpage>
            <pub-id pub-id-type="pmid">33023662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r117">
          <label>117</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tatekawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Oughourlian</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Hagiwara</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Raymond</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cloughesy</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Nghiemphu</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Liau</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Salamon</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ellingson</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI Study.</article-title>
            <source>Clin Nucl Med</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>45</volume>
            <issue>12</issue>
            <fpage>e505</fpage>
            <page-range>e505-e511</page-range>
            <pub-id pub-id-type="pmid">33031233</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r118">
          <label>118</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tatekawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hagiwara</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Oughourlian</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Ueda</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Uetani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Raymond</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cloughesy</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Nghiemphu</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Liau</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Pope</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Salamon</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ellingson</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Voxelwise and Patientwise Correlation of <sup>18</sup>F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Na&#x000ef;ve Diffuse Gliomas with Different Molecular Subtypes.</article-title>
            <source>J Nucl Med</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>62</volume>
            <issue>3</issue>
            <fpage>319</fpage>
            <page-range>319-325</page-range>
            <pub-id pub-id-type="pmid">32646876</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r119">
          <label>119</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Qian</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Herman</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Brinkmann</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Laack</surname>
                <given-names>NN</given-names>
              </name>
              <name>
                <surname>Kemp</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Hunt</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Lowe</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Pafundi</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Prediction of MGMT Status for Glioblastoma Patients Using Radiomics Feature Extraction From <sup>18</sup>F-DOPA-PET Imaging.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2020</year>
            <month>Dec</month>
            <day>01</day>
            <volume>108</volume>
            <issue>5</issue>
            <fpage>1339</fpage>
            <page-range>1339-1346</page-range>
            <pub-id pub-id-type="pmid">32634544</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r120">
          <label>120</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castello</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Riva</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fernandes</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bello</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lopci</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>The role of 11C-methionine PET in patients with negative diffusion-weighted magnetic resonance imaging: correlation with histology and molecular biomarkers in operated gliomas.</article-title>
            <source>Nucl Med Commun</source>
            <year>2020</year>
            <month>Jul</month>
            <volume>41</volume>
            <issue>7</issue>
            <fpage>696</fpage>
            <page-range>696-705</page-range>
            <pub-id pub-id-type="pmid">32371671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r121">
          <label>121</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spies</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Steyn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bussy</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Brits</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Forensic imaging: The sensitivities of various imaging modalities in detecting skeletal trauma in simulated cases of child abuse using a pig model.</article-title>
            <source>J Forensic Leg Med</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>76</volume>
            <fpage>102034</fpage>
            <pub-id pub-id-type="pmid">33208232</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r122">
          <label>122</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chuang</surname>
                <given-names>YW</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>YF</given-names>
              </name>
              <name>
                <surname>Tyan</surname>
                <given-names>YC</given-names>
              </name>
            </person-group>
            <article-title>Multiple Bony Injuries on Bone Scan in a Case of Unsuspected Child Abuse.</article-title>
            <source>Case Rep Med</source>
            <year>2017</year>
            <volume>2017</volume>
            <fpage>3015941</fpage>
            <pub-id pub-id-type="pmid">28740509</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r123">
          <label>123</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Born</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schwier</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Stoever</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mentzel</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Freiberg</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The German Evidence-Based Child Protection Guideline - Imaging in Suspected Child Abuse.</article-title>
            <source>Rofo</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>192</volume>
            <issue>4</issue>
            <fpage>343</fpage>
            <page-range>343-348</page-range>
            <pub-id pub-id-type="pmid">31747703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r124">
          <label>124</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bainbridge</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Huey</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Should bone scintigraphy be used as a routine adjunct to skeletal survey in the imaging of non-accidental injury? A 10 year review of reports in a single centre.</article-title>
            <source>Clin Radiol</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>70</volume>
            <issue>8</issue>
            <fpage>e83</fpage>
            <page-range>e83-9</page-range>
            <pub-id pub-id-type="pmid">26055408</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r125">
          <label>125</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drubach</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Nuclear Medicine Techniques in Pediatric Bone Imaging.</article-title>
            <source>Semin Nucl Med</source>
            <year>2017</year>
            <month>May</month>
            <volume>47</volume>
            <issue>3</issue>
            <fpage>190</fpage>
            <page-range>190-203</page-range>
            <pub-id pub-id-type="pmid">28417851</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r126">
          <label>126</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Valanne</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>F&#x000f6;hr</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>[Radiological examinations in suspected physical abuse of a child].</article-title>
            <source>Duodecim</source>
            <year>2015</year>
            <volume>131</volume>
            <issue>10</issue>
            <fpage>1000</fpage>
            <page-range>1000-7</page-range>
            <pub-id pub-id-type="pmid">26237881</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r127">
          <label>127</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grant</surname>
                <given-names>FD</given-names>
              </name>
            </person-group>
            <article-title>&#x000b9;&#x02078;F-fluoride PET and PET/CT in children and young adults.</article-title>
            <source>PET Clin</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>287</fpage>
            <page-range>287-97</page-range>
            <pub-id pub-id-type="pmid">25030392</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r128">
          <label>128</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Niccoli Asabella</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stabile Ianora</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Di Palo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rubini</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pisani</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Notaristefano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rubini</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>[Lung perfusion scintigraphy in pediatric patients with congenital malformations].</article-title>
            <source>Recenti Prog Med</source>
            <year>2013</year>
            <season>Jul-Aug</season>
            <volume>104</volume>
            <issue>7-8</issue>
            <fpage>442</fpage>
            <page-range>442-5</page-range>
            <pub-id pub-id-type="pmid">24042425</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r129">
          <label>129</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wise-Faberowski</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Irvin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lennig</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Long</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nadel</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Bauser-Heaton</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Asija</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hanley</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>McElhinney</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Assessment of the Reconstructed Pulmonary Circulation With Lung Perfusion Scintigraphy After Unifocalization and Repair of Tetralogy of Fallot With Major Aortopulmonary Collaterals.</article-title>
            <source>World J Pediatr Congenit Heart Surg</source>
            <year>2019</year>
            <month>May</month>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>313</fpage>
            <page-range>313-320</page-range>
            <pub-id pub-id-type="pmid">31084304</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r130">
          <label>130</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asabella</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Cimino</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Altini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lavelli</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Rubini</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Lung Perfusion Imaging in Tetralogy of Fallot: A Case Report.</article-title>
            <source>Mol Imaging Radionucl Ther</source>
            <year>2018</year>
            <month>Oct</month>
            <day>09</day>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>146</fpage>
            <page-range>146-148</page-range>
            <pub-id pub-id-type="pmid">30317856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r131">
          <label>131</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chien</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Weng</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Shieh</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Hsieh</surname>
                <given-names>KS</given-names>
              </name>
            </person-group>
            <article-title>Assessment of branch pulmonary artery stenosis in children after repair of tetralogy of Fallot using lung perfusion scintigraphy comparison with echocardiography.</article-title>
            <source>Ann Nucl Med</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-59</page-range>
            <pub-id pub-id-type="pmid">26493388</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r132">
          <label>132</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rubi&#x000f3; Rodr&#x000ed;guez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ferran Sureda</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Balliu Collgr&#x000f2;s</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Uriel Prat</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Galofr&#x000e9; Mora</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>[Unilateral ventilation/perfusi&#x000f3;n (V/Q) mismatch in a child with corrected congenital heart disease].</article-title>
            <source>Rev Esp Med Nucl</source>
            <year>2009</year>
            <season>Jan-Feb</season>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>30</fpage>
            <page-range>30-1</page-range>
            <pub-id pub-id-type="pmid">19232176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r133">
          <label>133</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kamal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sarvepalli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Selvakumar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lopez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Radhakrishnan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gabbard</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Assessment of Gastric Emptying Times Between Pediatrics and Adults With Cyclic Vomiting Syndrome.</article-title>
            <source>J Clin Gastroenterol</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>54</volume>
            <issue>9</issue>
            <fpage>e89</fpage>
            <page-range>e89-e92</page-range>
            <pub-id pub-id-type="pmid">32569030</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r134">
          <label>134</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kwatra</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Shalaby-Rana</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Andrich</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Ghelani</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Spottswood</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Majd</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Gastric emptying of milk in infants and children up to 5&#x000a0;years of age: normative data and influencing factors.</article-title>
            <source>Pediatr Radiol</source>
            <year>2020</year>
            <month>May</month>
            <volume>50</volume>
            <issue>5</issue>
            <fpage>689</fpage>
            <page-range>689-697</page-range>
            <pub-id pub-id-type="pmid">31993707</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r135">
          <label>135</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Edwards</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Cocjin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Theut</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Rivard</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sherman</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Friesen</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>A comparison of the diagnosis of gastroparesis in 4&#x02009;h pediatric gastric emptying studies versus 2&#x02009;h studies.</article-title>
            <source>BMC Gastroenterol</source>
            <year>2019</year>
            <month>Feb</month>
            <day>11</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>26</fpage>
            <pub-id pub-id-type="pmid">30744574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r136">
          <label>136</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Du</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ding</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Towbin</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>DeJonckheere</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hagerman</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Varughese</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Pratap</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Gastric emptying for liquids of different compositions in children.</article-title>
            <source>Br J Anaesth</source>
            <year>2017</year>
            <month>Nov</month>
            <day>01</day>
            <volume>119</volume>
            <issue>5</issue>
            <fpage>948</fpage>
            <page-range>948-955</page-range>
            <pub-id pub-id-type="pmid">29077812</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r137">
          <label>137</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Image characteristics and classification of salivagram in the diagnosis of pulmonary aspiration in children.</article-title>
            <source>Nucl Med Commun</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>38</volume>
            <issue>7</issue>
            <fpage>617</fpage>
            <page-range>617-622</page-range>
            <pub-id pub-id-type="pmid">28471844</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r138">
          <label>138</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shao</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Toyama</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ichihara</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zhuang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kung</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Semi-quantitative assessment optimized the grading of pulmonary aspiration on salivagram in children.</article-title>
            <source>Ann Nucl Med</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>321</fpage>
            <page-range>321-327</page-range>
            <pub-id pub-id-type="pmid">33555558</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r139">
          <label>139</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Sung</surname>
                <given-names>IY</given-names>
              </name>
              <name>
                <surname>Ko</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Comparison of Videofluoroscopic Swallowing Study and Radionuclide Salivagram for Aspiration Pneumonia in Children With Swallowing Difficulty.</article-title>
            <source>Ann Rehabil Med</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>42</volume>
            <issue>1</issue>
            <fpage>52</fpage>
            <page-range>52-58</page-range>
            <pub-id pub-id-type="pmid">29560324</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r140">
          <label>140</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Ting Kung</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sing Ng</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Effect of nasogastric tube on salivagram result in paediatric patients.</article-title>
            <source>Nucl Med Commun</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>40</volume>
            <issue>9</issue>
            <fpage>894</fpage>
            <page-range>894-897</page-range>
            <pub-id pub-id-type="pmid">31343616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r141">
          <label>141</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>More Evidence Is Warranted to Establish the Role of 18FDG-PET/CT in Fever of Unknown Origin (FUO) Investigations Among Children.</article-title>
            <source>Clin Infect Dis</source>
            <year>2021</year>
            <month>Nov</month>
            <day>02</day>
            <volume>73</volume>
            <issue>9</issue>
            <fpage>e2842</fpage>
            <page-range>e2842-e2844</page-range>
            <pub-id pub-id-type="pmid">33064795</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r142">
          <label>142</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pijl</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Kwee</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Legger</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>HJH</given-names>
              </name>
              <name>
                <surname>Armbrust</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sch&#x000f6;lvinck</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Glaudemans</surname>
                <given-names>AWJM</given-names>
              </name>
            </person-group>
            <article-title>Role of FDG-PET/CT in children with fever of unknown origin.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>47</volume>
            <issue>6</issue>
            <fpage>1596</fpage>
            <page-range>1596-1604</page-range>
            <pub-id pub-id-type="pmid">32030452</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r143">
          <label>143</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shimizu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ikawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mizuta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Takakura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Inoue</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yachie</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>FDG-PET in macrophage activation syndrome associated with systemic juvenile idiopathic arthritis.</article-title>
            <source>Pediatr Int</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>59</volume>
            <issue>4</issue>
            <fpage>509</fpage>
            <page-range>509-511</page-range>
            <pub-id pub-id-type="pmid">28401744</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r144">
          <label>144</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shimizu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saikawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yachie</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Role of 18-fluoro-2-deoxyglucose positron emission tomography in detecting acute inflammatory lesions of non-bacterial osteitis in patients with a fever of unknown origin: A comparative study of 18-fluoro-2-deoxyglucose positron emission tomography, bone scan, and magnetic resonance imaging.</article-title>
            <source>Mod Rheumatol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>28</volume>
            <issue>6</issue>
            <fpage>1058</fpage>
            <page-range>1058-1062</page-range>
            <pub-id pub-id-type="pmid">27321232</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r145">
          <label>145</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garg</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>DaSilva</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bhalakia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Milstein</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Utility of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in a child with chronic granulomatous disease.</article-title>
            <source>Indian J Nucl Med</source>
            <year>2016</year>
            <season>Jan-Mar</season>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>62</fpage>
            <page-range>62-4</page-range>
            <pub-id pub-id-type="pmid">26917900</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r146">
          <label>146</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Jou</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Ko</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Tzen</surname>
                <given-names>KY</given-names>
              </name>
              <name>
                <surname>Yen</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>Search of Unknown Fever Focus Using PET in Critically Ill Children With Complicated Underlying Diseases.</article-title>
            <source>Pediatr Crit Care Med</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>e58</fpage>
            <page-range>e58-65</page-range>
            <pub-id pub-id-type="pmid">26649939</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r147">
          <label>147</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jim&#x000e9;nez</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Soto</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez-Mart&#x000ed;nez</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Hern&#x000e1;ndez-L&#x000f3;pez</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lerma</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Barrag&#x000e1;n-Garfias</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-Torres</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hern&#x000e1;ndez-Lemus</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Guarner-Lans</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Assessment of inflammatory activity in Takayasu's arteritis: performance of clinical scores and common biomarkers versus 18F-FDG PET/CT.</article-title>
            <source>Clin Exp Rheumatol</source>
            <year>2021</year>
            <season>Sep-Oct</season>
            <volume>39</volume>
            <issue>5</issue>
            <fpage>1011</fpage>
            <page-range>1011-1020</page-range>
            <pub-id pub-id-type="pmid">33124558</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r148">
          <label>148</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kawamura</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ueno</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Taimura</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Matsuba</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Imoto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jinguji</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kawano</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Case Report: <sup>18</sup>F-FDG PET-CT for Diagnosing Prosthetic Device-Related Infection in an Infant With CHD.</article-title>
            <source>Front Pediatr</source>
            <year>2021</year>
            <volume>9</volume>
            <fpage>584741</fpage>
            <pub-id pub-id-type="pmid">33763393</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r149">
          <label>149</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aslanidis</surname>
                <given-names>IP</given-names>
              </name>
              <name>
                <surname>Pursanova</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Mukhortova</surname>
                <given-names>OV</given-names>
              </name>
              <name>
                <surname>Shurupova</surname>
                <given-names>IV</given-names>
              </name>
              <name>
                <surname>Ekaeva</surname>
                <given-names>IV</given-names>
              </name>
              <name>
                <surname>Arakelyan</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Golukhova</surname>
                <given-names>EZ</given-names>
              </name>
              <name>
                <surname>Mironenko</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Garmanov</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Popov</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>[18F-fluorodeoxyglucose PET/CT in the diagnosis of vascular graft infection].</article-title>
            <source>Khirurgiia (Mosk)</source>
            <year>2021</year>
            <issue>2</issue>
            <fpage>58</fpage>
            <page-range>58-66</page-range>
            <pub-id pub-id-type="pmid">33570356</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r150">
          <label>150</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cremer</surname>
                <given-names>PC</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic Uncertainty in Prosthetic Valve Endocarditis: Value of <sup>18</sup>F-FDG PET/CT and the Need for Standardization.</article-title>
            <source>JACC Cardiovasc Imaging</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>13</volume>
            <issue>12</issue>
            <fpage>2616</fpage>
            <page-range>2616-2618</page-range>
            <pub-id pub-id-type="pmid">32828768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r151">
          <label>151</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jer&#x000f3;nimo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Olmos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vilacosta</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ortega-Candil</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Rey</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-Castej&#x000f3;n</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-P&#x000e9;rez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-Garc&#x000ed;a</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Arribas</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ferrera</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Carreras</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Accuracy of <sup>18</sup>F-FDG PET/CT in patients with the suspicion of cardiac implantable electronic device infections.</article-title>
            <source>J Nucl Cardiol</source>
            <year>2022</year>
            <month>Apr</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>594</fpage>
            <page-range>594-608</page-range>
            <pub-id pub-id-type="pmid">32748277</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r152">
          <label>152</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gobbo</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Meretta</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Rosa</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Corneli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Daquarti</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Masoli</surname>
                <given-names>OH</given-names>
              </name>
              <name>
                <surname>Grymberg</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez Bali&#x000f1;o</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nacinovich</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ronderos</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>[Positron emission tomography in infective endocarditis associated with intracardiac devices and prosthetic valves].</article-title>
            <source>Medicina (B Aires)</source>
            <year>2020</year>
            <volume>80</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-22</page-range>
            <pub-id pub-id-type="pmid">32044737</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r153">
          <label>153</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Treglia</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic Performance of <sup>18</sup>F-FDG PET/CT in Infectious and Inflammatory Diseases according to Published Meta-Analyses.</article-title>
            <source>Contrast Media Mol Imaging</source>
            <year>2019</year>
            <volume>2019</volume>
            <fpage>3018349</fpage>
            <pub-id pub-id-type="pmid">31427907</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r154">
          <label>154</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sajadi</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Dilsizian</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Merits of FDG PET/CT and Functional Molecular&#x000a0;Imaging Over Anatomic Imaging&#x000a0;With&#x000a0;Echocardiography and CT&#x000a0;Angiography for the Diagnosis of Cardiac&#x000a0;Device&#x000a0;Infections.</article-title>
            <source>JACC Cardiovasc Imaging</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>11</volume>
            <issue>11</issue>
            <fpage>1679</fpage>
            <page-range>1679-1691</page-range>
            <pub-id pub-id-type="pmid">30409329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r155">
          <label>155</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Diemberger</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bonfiglioli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Martignani</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Graziosi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Biffi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lorenzetti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ziacchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nanni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fanti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Boriani</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>46</volume>
            <issue>1</issue>
            <fpage>194</fpage>
            <page-range>194-205</page-range>
            <pub-id pub-id-type="pmid">30196365</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r156">
          <label>156</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blanc</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bonnet</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Giordano</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Monteil</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Salabert</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Payoux</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The use of labelled leucocyte scintigraphy to evaluate chronic periprosthetic joint infections: a retrospective multicentre study on 168 patients.</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>38</volume>
            <issue>9</issue>
            <fpage>1625</fpage>
            <page-range>1625-1631</page-range>
            <pub-id pub-id-type="pmid">31218592</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128632.r157">
          <label>157</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Djekidel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Piert</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Benefits of hybrid SPECT/CT for (111)In-oxine- and Tc-99m-hexamethylpropylene amine oxime-labeled leukocyte imaging.</article-title>
            <source>Clin Nucl Med</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>36</volume>
            <issue>7</issue>
            <fpage>e50</fpage>
            <page-range>e50-6</page-range>
            <pub-id pub-id-type="pmid">21637042</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
